Abstract
Keywords
Onion Allium cepa Quercetin Thiosulphinates Phenolic acids Pharmacological properties
Introduction
Allium cepa (A. cepa) is a bulbous perennial or biennial monocot plant belonging to the family Liliaceae and the genus Allium, which includes over 250 genera and 3700 species (1-4). It is believed that the origin of A. cepa is central Asia, possibly the regions of Iran and Pakistan. However, it has now been distributed all over the world, such as Europe, North America and Africa (2, 5). A. cepa has several vernacular names like Onion in English, Cyvannulli in Malayalam, Pyaj in Hindi, Miruli in Kannada and Piaz in Farsi. The flowers of onion are small and usually purple or white. The root system of this plant is superficial and the stem at its base is very short flattened which increases in diameter as growth continues. The leaves of onion are long, linear, hollow and cylindrical. When the plant reaches a certain stage of growth, the leaf bases become thick and form a bulb (5). Onion is categorized based on their color into yellow, red and white and based on their taste as sweet and non-sweet (6, 7). This plant is used in many forms, including raw bulbs, fresh juice, fried and roasted (8-11).
Onion has been known that possesses various medicinal properties from ancient times (12). The plant is traditionally used to treat different diseases such as cough due to bronchitis, asthma, inflammatory disorders, dysentery, ulcer wounds, scars, keloids, pain and swelling after bee or wasp stings (13). Experimental researches have also shown numerous pharmacological effects for onion, including decreases blood levels of cholesterol, triglycerides and thromboxanes (substances involved in the development of cardiovascular disease), inhibits platelet aggregation and platelet-mediated thrombosis (a process resulting in heart attacks and strokes), functions as a hypoglycemic, neuroprotective, anti-convulsant, anti-hypertensive, anti-depressant and diuretic agent, protective effect on the liver, prevents the processes of oxidation and inflammation as well as the release of histamine associated with asthma, stimulates the immune system and decreases osteoporosis (14-32). Moreover, onion is one of the strongest anti-carcinogenic components because it suppresses the growth of carcinogenic cells (33).
This article reviews the pharmacological properties of onion and its constituents along with possible mechanisms in various fields.
Experimental
Materials and Methods
Databases including Google Scholar, PubMed, Medline, ISI Web of Knowledge, Science Direct and Scopus were searched for the terms such as “onion”, “Allium cepa”, “flavonoid”, “organosulfur”, “phenolic compounds”, “clinical trial” and “animal studies” to identify studies on pharmacological effects of A. cepa and constituents of onion and possible underlying mechanisms of these effects.
Results
Chemical constituents
Numerous effects of onion may be due to a wide range of constituents, including quercetin, thiosulphinates and phenolic acids which have often been reported from this plant. The preliminary phytochemical investigations have showed that onion contains water, carbohydrates (e.g. inulin, fructooligosaccharides, isorhamnetin-4-glucoside, galactose, glucose and mannose), proteins, vegetal hormone (glycoquinine), lectin, steroids, essential oils (e.g. catechol protocatechnic acid, thiocyanate and thiopropiono aldehyde), phytoestrogens (e.g. coumestrol, zearalenol, isoflavones and humulone), vitamins (e.g. A, B complex, C and E), minerals (e.g. selenium, phosphorus, iron, calcium and chromium), flavonoids (e.g. quercetin, apigenin, rutin, myricetin, kaempferol, catechin, resveratrol, epigallocatechol-3-gallate, luteolin and genistein), organosulfuric compounds (e.g. thiosulphinates, cepaenes, cysteine, S-methyl cysteine sulfoxide, diallyl disulfide, allyl methyl sulfide, allyl propyl disulfide, gamma-L-glutamyl-trans-S-1-propenyl-L-cysteine sulfoxide, S-propenyl cysteine sulfoxide, S-alk(en)yl cysteine sulfoxides and S-allyl cysteine sulfoxide) and allicin (e.g. Diallyl disulfide, diallyl trisulfide and ajoene), phenolic compounds (e.g. phenolics, phenolic acids, anthocyanins and hydroxycinnamic acid), lipophilic antioxidants (e.g. dialkyl disulfides), aglycones, anthocyanin, saponins and fistulosin (octadecyl 3-hydroxyindole) (5, 8, 27 and 34-48).
There are different flavonoids in onion skin, including quercetin aglycone, quercetin diglucoside, quercetin 4-glucoside and isorhamnetin monoglycoside or kaempferol monoglycoside (49). More than 80 percent of flavonoids exist in the outer scales of the onion because of exposure to sunlight. The plant also contains 1–5 percent dry weight of S-alk(en)yl cysteine sulfoxides that are precursors of its aroma (50).
Anti-cancer effects
Compelling evidence indicates that individuals who consume copious amounts of onion, their susceptibility to cancer at various organ sites is reduced (51-53). Polyphenolics such as flavonoids found in onion are partially responsible for this beneficial effect (42, 54). In addition, organosulfur compounds (e.g. cysteine, S-methyl cysteine, diallyl disulfide and diallyl trisulfide) content of onion play an important role in cancer chemoprevention as several studies are showing protective effects of these compounds against liver, stomach, colorectal and breast cancers (55-60). Moreover, onion, due to high-selenium content, can prevent some cancer occurrence without resulting in an excessive accumulation of tissue selenium, a concern associated with standard selenium compounds (61, 62).
Several mechanisms have been proposed to explain the cancer-preventive effects of onion and related constituents. For example, quercetin is able to prevent reactive oxygen species (ROS)-induced DNA damage and mutational changes, inhibit the activity of tyrosine kinases which are oncogenic and increase the bioavailability of some anti-cancer drugs (e.g. tamoxifen) by promoting their intestinal absorption and decreasing their metabolism (63-65). In the case of organosulfur compounds, it is suggested that they induce phase II detoxifying enzymes, including quinone reductase and glutathione S-transferase and increase the activities of glutathione reductase, glutathione peroxidase (GPx) and superoxide dismutase (SOD) leading to carcinogen detoxification and elimination (66-68). These compounds also affect sulfhydryl/disulfide exchange reactions or induce apoptosis that are probably crucial for controlling cell proliferation and tumor growth (69-71). Moreover, organosulfur compounds stimulate glutathione (GSH) synthesis, the enzyme necessary for conjugating GSH to electrophiles and blocking DNA-adduct formation (72). Other mechanisms that organosulfur compounds exert anti-cancer effects include modulation of multidrug resistance enzymes which are very useful for improving the response of cancers to chemo-therapies, blockade of the formation of the cancer-causing substance, inactivation of cancer-causing substances and an increase of DNA repair (73-75).
In-vitro studies
Some studies have demonstrated anti-cancer effects of onion on different malignant cells in-vitro. For example, the preventive effect of onion oil on skin tumor promotion through an increase in GSH activity was reported (72). In the study done by Wang et al., ethyl acetate extract of onion inhibited fatty acid synthase and induced apoptosis in fatty acid synthase over-expressing human breast cancer cells. Since obesity is closely associated with breast cancer, the results of this study suggested that onion might be valuable for preventing obesity-related malignancy (53). The anti-proliferative effect of onion on gastric and breast cancers in human cells by inducing apoptosis was also demonstrated (76). In addition, Shrivastava et al. investigated the protective effects of aqueous extract of onion on Melanoma cells. This study revealed significant activity of onion as a cytoprotective agent of normal cells and cytotoxicity agent for tumor cells as a considerable decrease in Melanoma cell population by crude extract of the plant (77). Another in-vitro study evaluated the effects of onion against telomerase activity of HL-60 cells and exhibited both telomerase inhibitory effect and cancer cell proliferation inhibitory effect with onion administration (78).
There is also substantial in-vitro research that has examined the anti-cancer effects of different compounds of onion. For example, one study indicated anti-cancer effects of polyphenols in human leukemia cells by inducing caspase-dependent apoptosis. The apoptosis was triggered through the extrinsic pathway by up-regulating death receptor 5 as well as by the intrinsic pathway by a down-regulating cellular inhibitor of apoptosis 1 family member (79). Another study approved the potency of quercetin against human breast cancer by inhibiting cancer cell growth and induction of apoptosis in cancer cells (80). Several studies on quercetin, an important ingredient of onion, has shown that this agent could be an anticarcinogen for numerous cancer types including breast cancer, leukemia, colon, squamous cell, ovary, endometrial, gastric and non-small-cell lung (81-90). Quercetin was also found to down regulate the expression of mutant p53 protein in human breast cancer cell lines resulting in arresting cells in the G2-M phase of the cell cycle (91, 92).
Moreover, the investigators reported the anti-proliferative effects of diallyl disulfide and diallyl trisulfide on cultured human neoplastic and non-neoplastic lung cells (93). In 2002, it was shown a significant dose-dependent cytotoxic response of diallyl disulfide on ascites tumor cells (94). It has also been demonstrated that treatment of human tumor cells with diallyl disulfide resulted in the complete cessation of growth through a proportional increase in the percentage of cells arrested in the G2-M phase of the cell cycle (95, 96).
In-vivo studies
There are epidemiological and experimental studies that indicate the anti-cancer effects of onion. In a French epidemiological study, a higher intake of onion was associated with a lower risk of breast cancer (97). Another study done in northeast China revealed an inverse relationship between onion consumption and brain cancer (98). Also, decreased risk of gastric cancer with increased intake of onion has been reported (99). In case-control investigations, it was reported that onion consumers had a lower risk of large bowel cancer compared to controls (51). The relationship between onion intake and incidence of colorectal adenoma was also assessed using 562 cases and 5,932 controls from subjects in the prostate, lung, colorectal, and ovarian cancer screening trial which demonstrated the protective effects of onion intake on these cancers. In another study, Chen et al. indicated that Taiwanese onion consumers had a lower risk of esophageal cancer (100, 101). These beneficial effects of onion consumption have also been observed in oral cavity/pharyngeal, laryngeal, lung, pancreatic, prostate and ovarian cancers (88, 102-104). Moreover, an experimental study was designed to evaluate the protective effect of onion on colorectal cancer with hyperlipidemia. This study showed that the proliferation of colorectal cancer with onion administration was significantly inhibited in mice (105).
Several pieces of evidence also demonstrate the anti-cancer effects of different constituents found in onion. Former studies have reported that high intakes of flavonoids are correlated with a lower risk of cancer (102). In patients with advanced cancers, intravenous administration of quercetin inhibited the proliferation of cancerous cells (106). Similarly, in the study of Molnar et al., quercetin when was given intraperitoneally to animals with ascetic tumors showed anti-tumor effects (107). Another animal study examined the effect of quercetin on mice bearing abdominal tumors derived from a human pharyngeal squamous cell carcinoma line. The result of this study revealed that quercetin exerted significant inhibition of tumor growth (86). Besides, the protective effect of organosulfur compounds (e.g. diallyl disulfide and diallyl trisulfide) against carcinogenesis was examined in animal models. When administered to mice, those constituents inhibited pulmonary adenoma formation, gastric neoplasia and growth of hepatoma (108, 109). Moreover, the anti-tumor properties of diallyl disulfide were shown in various experimental studies (110, 111). Another compound found in onion, steroidal saponins also have anti-cancer potential against lung carcinoma, melanoma and leukemia (112, 113). Anti-cancer effects of onion and its constituents were shown in Table 1. The summary of the anti-cancer effects of onion was demonstrated in Figure 1.
According to the studies mentioned above, onion acts as an anti-cancer agent by increasing detoxification enzymes, preventing cell division and inhibiting cellular proliferation. Some constituents found in onion also have anti-cancer properties. For example, quercetin prevents mutational changes, inhibits the activity of tyrosine kinases and increases the bioavailability of some anti-cancer drugs. Allins and quercetin are able to inhibit the growth of malignant cells. Organosulfur compounds have chemo-preventive activity.
Anti-diabetic effects
The available evidence shows that onion possesses anti-diabetic effects (114-118). One of the most important applications of onion in traditional medicine is its use for the treatment of diabetes to lower blood glucose levels. Extracts of onion also modulate the liver hexokinase activity glucose 6-phosphatase and HMG coenzyme-A reductase and normalize the plasma level of lipid and glucose. Consuming onion results in hypoglycemia in diabetic patients (1). Treatment of streptozotocin (STZ)-induced diabetic rats with red onion extract showed decreased fasting blood glucose (FBG) levels and improved glycation end products (AGEs). Increased serum insulin levels and suppressing inflammatory mRNA expression were also observed in treated animals with the extract which were due to hyperglycemia (119). In another study, 100 g daily intake of onion in both type1 and 2 diabetic patients resulted in a significant decrease in FBG compared to insulin which was about 89 and 40 mg/dL in type 1 and 2 diabetic patients, respectively.
The results suggest that the anti-diabetic effect of onion could be due to the recovery or reproduction of pancreatic beta cells and improves the activity of enzymes in the pathways of glycolysis and gluconeogenesis (120). Oral supplementation of onion in STZ-induced diabetic rats resulted in decreasing nitric oxide production in diabetic animals. Therefore, orally onion treatment increased the expression of cardiac inducible nitric oxide synthase (iNOS) protein and mRNA expression resulting in reduced cardiac vascular damage due to diabetes (121). Since diabetes is associated with oxidative stress due to the compromise of natural antioxidant mechanisms and an increase in oxygen-free radical production, the reduction of oxidative stress may have potential therapeutic effects (122). Various studies have demonstrated that treatment with onion causes a decrease in free radicals because of the presence of components such as S-methyl cysteine sulfoxide (123, 124). This component also stimulates insulin secretion, controls blood glucose and normalizes the activities of liver hexokinase, glucose 6-phosphatase and HMG-CoA reductase enzymes (123, 125). S-allyl cysteine sulfoxide, another constituent found in onion, has been reported to have therapeutic effects on diabetes by stimulating the production and secretion of insulin, interfering with dietary glucose absorption and favoring insulin saving (126, 127). In addition, allyl propyl disulfide and chromium content in onion have ability to decrease fasting blood levels of glucose and insulin and increase glucose tolerance (5). Quercetin by inhibiting α-glucosidase is also able to prevent the release of D-glucose from oligosaccharides and disaccharides resulting in delayed absorption of glucose from intestine and controlling blood glucose levels (128, 129). Additionally, quercetin can improve glucose-induced insulin secretion and protect pancreatic islets against oxidative damage through phosphorylation of extracellular signal-regulated kinase (ERK) (130, 131). Anti-diabetic effects of onion and its constituents were indicated in Table 2. The anti-diabetic effects of onion were demonstrated in Figure 2.
In summary, onion has anti-diabetic effects due to the presence of various constituents. For example, S-methyl cysteine sulfoxide can stimulate insulin secretion, control blood glucose and normalize the activities of liver hexokinase, glucose 6-phosphatase and HMG-CoA reductase enzymes. S-allyl cysteine sulfoxide stimulates the production and secretion of insulin, decreases dietary glucose absorption and saves insulin. Allyl propyl disulfide and chromium decrease fasting blood levels of glucose and insulin and increase glucose tolerance. Quercetin controls blood glucose levels, improves glucose-induced insulin secretion and protects pancreatic islets.
Anti-platelet effects
The researchers have demonstrated that administration of onion essential oil increases the coagulation time and fibrinolytic activity (5). Onion has been reported to reduce platelet aggregation by blocking thromboxane and prostaglandin biosynthesis and preventing thrombus growth and promotion of fibrinolysis. This plant also increases the coagulation time and fibrinolytic activity (132-136). Concerning the mechanism of the anti-platelet effect of onions, it can be noted that onion peel and bulbs extract through its constituents, quercetin, adenosine, allicin, and paraffinic polysulphides with upregulation of cyclic adenosine monophosphate (cAMP) levels and down regulation of thromboxane A2 (TXA2) through reducing the [Ca2+], cyclooxygenase (COX)-1 and TXA2 synthase activities with TXA2/prostaglandin (PG) H2 receptor blockade lead to inhibition of platelet aggregation (17, 137). Also, onion extract reduces platelet aggregation without interfering with COX activity on arachidonic acid (138). Another mechanism for these properties was that sulfur, trisulfide, allicin, adenosine and quercetin were able to reduce TXB2 biosynthesis via suppression of COX-1 (139). Also, trisulfides which are the major constituent of onion through two mechanisms showed anti-platelet activity, including 1) inhibition of TXA2 biosynthesis by suppressing thromboxane synthase and 2) reduction of TXB2 biosynthesis by inhibiting COX-1 (140). It may appear that the mentioned properties of the plant are due to the presence of organosulfur components (35, 133 and 141). However, non-sulfur compounds present in onion such as quercetin and some phenolics can also act as anti-platelet agents (35, 142). Anti-platelet effects of onion and its constituents were shown in Table 2. The summary of the anti-platelet effects of onion was demonstrated in Figure 3.
Bone effects
Onion has been shown to inhibit the activation and formation of osteoclast precursor cells and bone desorption as the plant decreases urinary excretion of [H3]-tetracycline, an index of bone desorption (143-146). Similarly, the study done by Wetli et al. indicated that one gram of onion added to the food of rats considerably inhibited bone reabsorption (147). In another experimental study, supplementing the diet of rats with onion powder also led to significant inhibition of bone reabsorption (148). It was demonstrated that onion administration attenuated the activation of ERK, p38 mitogen-activated protein kinases and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) induced by receptor activator of nuclear factor-kappa Β ligand (RANKL) (149). Because of the beneficial effects of onion on bones, it might be essentially valuable for menopause women who are at risk of osteoporosis (5). It has been suggested that one of the mechanisms of bone protection by onion is attributed to its base excess which is claimed to maintain calcium in bones (32, 150). In addition, quercetin present in onion has potential benefits for bone health by modulating inflammatory processes, downregulating NF-𝜅B, increasing NF-𝜅B’s cytoplasmic trapper protein expression and maintaining IkappaB-alpha (IκBα). Along with this, one in-vitro study showed that quercetin exerted an inhibitory effect on osteoclastic differentiation via a mechanism involving NF-κB and activator protein 1 (151). Quercetin also can inhibit the secretion of cytokines like interleukin (IL)-1𝛼, IL-6 and tumor necrosis factor-alpha (TNF-𝛼) which are involved in osteoclastogenesis and stimulate the secretion of IL-3 and IL-4 which are responsible for inhibition of osteoclast formation (152). Moreover, 1-propenyl-cysteine sulfoxide isolated from onion can inhibit osteoclast activity (5). Other constituents in onion such as rutin, several phytoestrogens (e.g. coumestrol, zearalenol, isoflavones and humulone) and vitamins (e.g. K and C) have been proposed to might be worthwhile for bone health (37, 46-48, 143 and 153). The effects of onion and its constituents on bone were shown in Table 3. The summary of the effects of onion on the bone cell was demonstrated in Figure 4.
Considering the above mentioned, onion has protective effects on bone via inhibiting the activation and formation of osteoclast precursor cells and bone desorption due to the presence of constituents such as quercetin, 1-propenyl-cysteine sulfoxide, phytoestrogens (e.g. coumestrol, zearalenol, isoflavones and humulone) and vitamins (e.g. K and C).
Cardiovascular effects
Methanol-soluble extract of onion on ischemic injury in heart-derived H9c2 cells in-vitro and in rat hearts in-vivo inhibited increases in the ROS, mitochondrial membrane depolarization, cytochrome c release and caspase-3 activation during hypoxia in H9c2 cells. In the in-vivo rat myocardial infarction model, onion extract considerably decreased the infarct size, apoptotic cell death of heart and plasma malondialdehyde (MDA) level. Therefore, the methanolic extract of onion showed a preventive effect on ischemia/hypoxia-induced apoptotic death in H9c2 cells and rat heart (154). In another study, it was found that the aqueous extract of onion could act as a cardioprotective agent against myocardial injury (155). A study indicates that aqueous onion extract reduces aortic nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity and lipid peroxidation resulting in reducing systolic blood pressure (156). Along with this, Nausheen et al. demonstrated that the antioxidant activity of onion leaves extract resulted in protection against doxorubicin-induced cardiotoxicity in rats (157). In another experimental study, the antihypertensive effects of onion in NG-nitro-L-arginine methyl ester-induced hypertensive rats due to the antioxidant activity of onion were shown (158). The plant may also be considered as a heart tonic agent (159). In addition, onion is able to induce endothelium-dependent vasorelaxation and increase vascular cyclic guanosine monophosphate (cGMP) levels (160).
Moreover, the effect of onion extract on serum concentration of cholesterol, triglycerides and low-density lipoproteins (LDL) was examined and the results showed that serum lipids were significantly reduced consequent consumption of onion extract (161). Some evidence has shown that quercetin found in this plant protects against coronary heart disease (162-164). Quercetin also decreases elevated blood pressure and cardiac hypertrophy (165). A group of researchers have suggested that the effect of this constituent on suppressing the elevation of blood pressure may be through the increase in nitric oxide (NO) availability and nitric oxide synthase (NOS) activity and decrease in angiotensin II production (166). Furthermore, quercetin prevents atherosclerosis by inhibiting lipid peroxidation (167). S-alk(en)yl cysteine sulfoxide, another component of onion, has been shown to reduce serum LDL cholesterol, protect LDL cholesterol from oxidation and raise high-density lipoproteins (HDL) cholesterol (168-170). Moreover, some studies have demonstrated that S-methyl cysteine sulfoxide isolated from onion possesses anti-oxidative and hypolipidemia properties (171-173). The effects of onion and its constituents on cardiovascular were indicated in Table 3. The summary of various effects of onion on cardiovascular system was shown in Figure 5.
In summary, onion can be considered as a protective cardiovascular agent because it is able to reduce systolic blood pressure. Several constituents of this plant have also shown these beneficial effects. For example, quercetin causes decreases in elevated blood pressure, cardiac hypertrophy and atherosclerosis. S-alk(en)yl cysteine sulfoxide reduces serum LDL cholesterol and raises HDL cholesterol. In addition, S-methyl cysteine sulfoxide results in hypolipidemia.
Gastrointestinal effects
Onion has been indicated to reduce food transit time in the gastrointestinal tract (174). Some studies have also shown that this plant stimulates the growth of useful microorganisms such as bifidobacteria and lactobacilli in the colon due to its high soluble fiber content, including inulin and fructooligosaccharides (40, 175). Another study revealed that onion administration for 28 consecutive days restored the activities of aspartate aminotransferase (AST), alanine transaminase (ALT) and lactate dehydrogenase (LDH) enzymes to their normal levels and reduced plasma bilirubin (123). In addition, it has been reported that flavonoids (e.g. quercetin) content in onion has anti-spasmodic and anti-diarrheal activities (176). Moreover, quercetin appears to have a therapeutic potential in treating peptic ulcers by promoting mucus secretion and the inhibitory effect on Helicobacter pylori growth (177, 178). Administration of 1.5, 02 and 2.5 g/kg of onion powder to chicks led to increased weight gain and feed consumption. Also, supplementation of onion reduced the population of E. coli and enhanced Lactobacillus and Streptococcus species. In addition, this study showed that onion increased the morphometry of length, width, crypt depth and surface area of the villus in the duodenum, jejunum and ileum of the small intestine (179). Feeding with a combination of onion and coconut for 8 days to sheep with gastrointestinal nematodes and cestodes resulted in increased body weight and apparently worm reduction (180). Maitham et al. showed that onion bulb extract with doses of 100–200 mg/kg reduced the size of the dextran sulfate sodium-induced colitis. Also, this extract led to a decrease in pro-inflammatory cytokines and signaling pathways such as mitogen-activated protein kinase family, rapamycin, COX-2 and tissue inhibitors of metalloproteinases. In addition, the expression of interferon-γ (IFN-γ), C-X-C chemokines and factors involved in apoptosis such as cytochrome c, caspase-3 and 8 were reduced with onion bulb extract (181). The effects of onion and its constituents on gastrointestinal were summarized in Table 4. Various effects of onion on the gastrointestinal system were summarized in Figure 6.
According to the above mentioned, onion has protective effects on the gastrointestinal system. This plant causes the reduction of food transit time in the gastrointestinal tract and stimulation of useful microorganism growth, normalization of AST, ALT and LDH activities. Some onion constituents have also shown these beneficial properties. For example, flavonoids (e.g. quercetin) have anti-spasmodic and anti-diarrheal activities. In addition, quercetin promotes mucus secretion and inhibits Helicobacter pylori growth resulting in the mitigation of peptic ulcers.
Nervous system effects
It has been shown that onion administration causes improvements in behavioral deficits, motor incoordination and short-term memory induced by cerebral ischemia-reperfusion (IR) through decreasing LDL cholesterol and lipid peroxidation while increasing GSH and catalase (CAT) activities (5, 182). The anti-oxidative effects of this plant are attributed to bioactive constituents such as flavonoids and organosulfur compounds (19, 183-186). The protective effects of methanolic extract of onion on cerebral IR were examined. The results indicated that administration of the extract reduced thiobarbituric acid reactive substances (TBARS) concentration in brain mitochondria and cerebral infarct size and prevented motor incoordination (19). Tamtaji et al. reported that onion ethanolic extract (125 and 250 mg/kg/day) for 4 weeks improves learning and memory performances, decreases the escape latency and traveled distance, and increases step-through latency in the Morris water maze and passive avoidance tests (187). Hydro-alcoholic extract of onion for 60 days improves motor incoordination and memory deficit, decreases oxidative stress and increases acetylcholinesterase (AChE) in neurotoxicity induced by aluminum chloride (182). Treatment with onion extract (200 mg/kg/day), dissolved in water for 14 days, also affects single immobilization stress-induced biochemical and behavioral changes in mice by decreases in the immobilization stress-induced anxiety and brain lipid peroxidation as well as increase of antioxidant enzymes activities. Therefore, these findings suggest that onion supplementation may be helpful in the treatment of anxiety and depression (188). The effects of onion and its constituents on the nervous system were shown in Table 4. Various effects of onion and its components on the nervous system were shown in Figure 7.
As indicated, onion shows the protective effects on the nervous system through improvements in behavioral deficits, motor incoordination and short-term memory and reduction of cerebral infarct size.
Respiratory effects
The available data indicates that onion treatment can protect from bronchial asthma (189, 190). In an animal study, the aqueous extract of onion caused the reduction of lung inflammation and neutrophil, eosinophil and lymphocyte count (12). Another report showed that the methanolic onion extract decreased inflammatory cytokines (e.g. IL-5 and IL-13) and eosinophil peroxidase activity. The extract also relaxes tracheal smooth muscle (191). On the other hand, onion has been demonstrated to reduce vascular permeability resulting in a decrease of protein exudation in bronchoalveolar lavage fluid (29). Also, treatment of asthmatic rats with onion showed a significant decline in tracheal response to methacholine and decreased total WBC and phospholipases A2 (PLA2) levels compared to the untreated asthmatic group (192). In addition, the antioxidant and immunomodulatory properties of onion were demonstrated in sensitized rats by decreasing of nitrogen dioxide (NO2), nitrate (NO3), immunoglobulin E (IgE), MDA and IL-4 levels but increased SOD, CAT and IFN-γ levels and IFN-γ/IL-4 ratio (193). Onion attenuates bronchial asthma as it relaxes tracheal smooth muscle and causes decreases in neutrophil, eosinophil and lymphocyte counts, inflammatory cytokines (e.g. IL-5 and IL-13), eosinophil peroxidase activity and protein exudation in bronchoalveolar lavage fluid. Some constituents also have these protective effects. Flavonoids (e.g. quercetin) act as an anti-asthmatic through the reduction of inflammatory indices (e.g. NF-κB, PGD2, leukotrienes and granulocyte macrophage-colony stimulating factor (GM-CSF)) and suppression of T helper (Th) 2 cytokine synthesis (e.g. IL-4 and IL-13) (194). Treatment with onion extract resulted in increased levels of CAT and SOD activity in rats exposed to nicotine. This increase in antioxidant factors was greater in all tissues than in the vitamin E treated group. Besides, treatment with onion supplementation decreased lipid peroxidation and increased all antioxidant markers in the liver tissue nicotine-treated rats (194). Onion also showed protective effects on carbon monoxide-induced tissue damage in rats by decreased oxidative stress metabolites such as protein carbonyl (PC), MDA, isoprostanes (F2IsoP) levels and increased SOD, CAT, and GPx (195). Also, it was reported that onion extract attenuates the pathological effect of nicotine in lung rats by antioxidative and anti-lipid peroxidative mechanisms (196). Onion also could be effective as a therapeutic agent in allergic rhinitis allergic. In addition, onion and its constituents could be considered as bronchodilatory drugs for the treatment of obstructive pulmonary diseases (197).
It has been suggested that flavonoids (e.g. quercetin) present in onion possess anti-asthmatic properties through a reduction in oxidative markers including MDA and inflammatory indices (e.g. NF-κB, PGD2, leukotrienes and GM-CSF), elevation in antioxidants such SOD and suppression of Th2 cytokine synthesis (e.g. IL-4 and IL-13) (198-202). Quercetin and polyphenols can also inhibit the release of histamine from basophils and mast cells and modulate the process of allergic sensitization (203-206). Moreover, the anti-inflammatory activity of quercetin and its inhibitory effect on muscarinic receptors in bronchial smooth muscle cells prevent bronchoconstriction in asthma (207). In addition to quercetin, kaempferol, thiosulfinates and cepaenes isolated from onion prevent bronchoconstriction by inhibiting cyclooxygenase and lipoxygenase enzymes (133, 208). In mice models of asthma, isoquercitrin or quercetin, reduced eosinophil counts in the bronchoalveolar lavage fluid (BALF), blood and lung parenchyma, neutrophil counts in blood but only isoquercitrin reduced IL-5 levels in lung homogenate (209). In asthma models of mice, quercetin reduced levels of IL-4 and Th2 cytokine, but increased IFN-γ and Th1 cytokine production which indicates the therapeutic effect of quercetin on asthma by improving Th1/Th2 balance (210). Another constituent of the plant, resveratrol, can improve a skewed balance of Th1/Th2 and suppress antigen-specific IgE antibody formation (209-211). Other constituents of onion such as Alkenys also inhibited 5-lipoxygenase, histamine release, leukotriene (LT) B4 and LTC4 biosynthesis from human polymorphonuclear leucocytes, thromboxane B2 (TXB2) biosynthesis by human platelets and allergen (212). The anti-asthmatic and anti-inflammatory effects of onions depend in part on the thiosulfinate moiety.
Topical administration of onion extract on nasal cavity mice model of allergic rhinitis caused a reduction of allergic symptom score, serum levels of total and ovalbumin (OVA)-specific IgE, cytokine levels of nasal mucosa including IL-4, IL-5, IL-10, IL-13, IFN-γ, TNF-α and COX-2 and eosinophilic infiltration. Therefore, topical application of onion extract decreased allergic symptoms by reducing the allergic inflammation and suppressing the Th1 and Th2 cytokine release (30).
The potent and concentration-dependent relaxant effect of A. cepa extract on tracheal smooth muscle compared to the effect of theophylline was also reported due to its β2-adrenergic stimulatory and/or calcium channel blockade possible mechanisms (213). Quercetin also showed a concentration-dependent inhibition of tracheal smooth muscle contractions induced by carbachol and electrical field stimulation (214). Alkenes compounds of onion inhibited platelet activating factor (PAF)-induced bronchial obstruction in guinea pigs (212). It was also shown that Isoquercitrin inhibited tracheal smooth muscle contractile response to OVA and LTD4 (215). The above studies suggest the bronchodilatory effect of onion and its constituents on obstructive pulmonary diseases.
However, some studies showed an allergic reaction to onion due to the production of IgE and cell-mediated mechanisms against plant lipid transfer proteins (LTPs) (216) which was considered as a cause of asthma induced by the handling of onions. However, despite the wide use of onion in food, few studies reported allergic reactions due to onion ingestion (217).
The effects of onion and its constituents on the respiratory system were indicated in Table 5. The effects of onion and its constituents on the respiratory system were shown in Figure 8.
Considering the above mentioned, onion has beneficial effects on the respiratory system. For example, this plant attenuates bronchial asthma as it relaxes tracheal smooth muscle and causes the decreases in neutrophil, eosinophil and lymphocyte counts, inflammatory cytokines (e.g. IL-5 and IL-13), eosinophil peroxidase activity and protein exudation in bronchoalveolar lavage fluid. Some constituents also have these protective effects. Flavonoids (e.g. quercetin) act as an anti-asthmatic through the reduction of inflammatory indices (e.g. NF-κB and PGD2, leukotrienes and GM-CSF) and suppression of Th2 cytokine synthesis (e.g. IL-4 and IL-13). Quercetin and polyphenols inhibit the release of histamine and modulate the process of allergic sensitization. Quercetin, kaempferol, thiosulfinates and cepaenes can prevent bronchoconstriction. Resveratrol improves a skewed balance of Th1/Th2 and suppresses antigen-specific IgE antibody formation.
Urogenital effects
Onion increases libido and strengthens reproductive organs against sexual impotence (5). An in-vivo study was designed to evaluate the androgenic effects of onion on spermatogenesis. It was observed that treatment with fresh onion juice significantly increased sperm motility and sperm viability as well as decreased the percentage of sperm head abnormalities (44). The protective mechanism of onion juice might be due to antioxidant compounds (e.g. vitamin C) against oxidative stress which has been demonstrated as one factor that affects fertility (23). Several studies have shown that quercetin found in onion has anti-protozoal effects and causes reduction of prostate weight together resulting in the decrease of prostate cancer risk. Quercetin administration also improves prostatitis and prostatodynia (218-220). In an animal study of polycystic ovary syndrome (PCOS), oral treatment with onion for 60 consecutive days increased levels of total antioxidant capacity (TAC), SOD and CAT and reduced MDA (221). Consumption of onion also leads to modulation of the apoptotic process in the ovary by increasing the level of antioxidants (222). Orally treatment of red onion scales (75, 150, and 300 mg/kg/day for 30 days) in Atypical prostatic hyperplasia (APH)-induced prostatic rats ameliorated hyperplasia and inflammation as well as increased apoptosis and suppressed expressions of the inflammatory cytokines such as tissue IL-6, IL-8, TNF-α and insulin-like growth factor 1 (IGF-1) (219). The onion extract is known to elevate testosterone levels which the mechanism of this increase is increasing production of luteinizing hormones, elimination of free radicals by strengthening the antioxidant defense system in the testicular tissue and altering the activity of the adenosine 50-monophosphate as well as activating protein kinase enzyme (223).
It has been reported that onion possesses a diuretic effect. In addition, the syrup of the plant is useful in extracting renal stones (5). A recent attempt was made to investigate the nephroprotective activity of onion in gentamicin-induced nephrotoxicity. The authors indicated that onion treatment dose-dependently reduced the elevated serum creatinine (Cr) and mitigated renal histopathological damages (e.g. dilated tubules and degeneration of epithelial lining) (24). In another study, onion significantly decreased the plasma level of urea in alloxan-diabetic rats (123). The effects of onion and its constituents on the respiratory and urogenital system were reported in Table 5. The effects of onion and its constituents on the urogenital system were demonstrated in Figure 9.
As indicated, onion has beneficial effects on the urogenital system. This plant causes increases in libido, sperm motility and sperm viability, as well as the decrease of the sperm head abnormalities and improvement of sexual impotencegenesis. In addition, quercetin can improve prostatitis and prostatodynia and reduce prostate cancer risk. Onion has a diuretic property and results in extracting renal stones. This plant reduces the elevated Cr and urea levels and attenuates renal histopathological damages.
Anti-cancer effects of A. cepa (onion) and its constituents
| Ref. | Effect | Extract/Constituent | Experimental model | |
|---|---|---|---|---|
| (67) | Chemo-preventive effects | Diallyl sulfide, disulfide, dipropyl sulfide and dipropyl disulfide | Exper. | Anti-cancer effects |
| (212) | Inhibited all stages of skin tumorigenesis | Onion oil | ||
| (30) | Inhibited metastatic potential and growth of melanoma | Quercetin, apigenin, epigallocathechin-3-gallate and resveratrol | ||
| (213, 221) | Inhibition of growth and proliferation of cancer cell lines | Quercetin | ||
| (64) | Increased intestinal absorption, decreased first-pass metabolism of tamoxifen | Quercetin | ||
| (63) | Prevention of radio-resistance following radiotherapy | Phenolic compounds | ||
| (65) | Increased bioavailability of anti-cancer drugs | Flavonoids | ||
| (214) | Inhibited the formation of DNA adducts and proliferation of several tumor cell lines, increased glutathione S-transferase activity | Organosulfur compounds | ||
| (215) | Increased glutathione S-transferase activity, decreased the number of aberrant crypt foci (precursors of colon cancers) | Organosulfur compounds | ||
| (112, 113) | Inhibited the proliferation of several cancer cell lines | Saponins | ||
| (98) | Decreased the brain cancer risk | Onion | ||
| (221) | Decreased the lung cancer risk | Flavonoids | ||
Anti-diabetic and anti-platlet effects of A. cepa (onion) and its constituents
| Ref. | Effect | Extract/ | Experimental model | |
|---|---|---|---|---|
| (114) | Decreased blood glucose levels, increased serum insulin levels | Onion oil | Exper. | Anti-diabetic effects |
| (116) | Decreased hyperglycemia | Onion powder | ||
| (123) | Decreased serum glucose levels | Onion juice | ||
| (124) | Decrease of hyperglycemia | Onion solution | ||
| (125) | Normalized blood glucose levels, glucose 6 phosphatase and liver hexokinase activities | S-methyl cysteine sulfoxide | ||
| (127) | Increased production and secretion of insulin, decrease in dietary glucose absorption | S-allyl cysteine sulfoxide | ||
| (5) | Decreased blood glucose levels | allyl propyl disulfide and chromium | ||
| (128, 129) | Inhibited the release of D-glucose from oligosaccharides and disaccharides, delayed glucose absorption from small intestine | Quercetin | ||
| (44, 131) | Decreased serum glucose levels, increased serum insulin levels, protection of pancreatic islets | Quercetin | ||
| (118) | Decreased blood glucose levels | Onion | Clin. | |
| (125) | Control of post-prandial glucose levels | Onion juice | ||
| (5) | Fibrinolytic effects, increased the coagulation time | Onion oil | Exper. | Anti-platlete effects |
| (141) | Inhibited platelet aggregation | Aqueous extract of raw onion | ||
| (142) | Inhibited platelet aggregation | Methanol extract of onion | ||
| (133, 134, 136) | Inhibited platelet aggregation and thromboxane B2 synthesis | Organosulfur components and quercetin | ||
| (132) | Inhibited platelet aggregation, suppressed the formation of all oxygenase products | Onion oil | Clin. | |
The effects of A. cepa (onion) and its constituents on bone and cardiovascular system
| Ref. | Effect | Extract/ | Experimental model | |
|---|---|---|---|---|
| (144-146) | Inhibited bone resorption, increased total bone mineral content | Onion | Exper. | Bone effects |
| (149) | Inhibited osteoclastogenesis | Water solution of onion crude powder | ||
| (152) | Inhibited osteoclastogenesis and osteoclast formation | Quercetin | ||
| (5) | Inhibited osteoclast activity | Propenyl-cysteine sulfoxide | ||
| (37, 153) | Decreased bone loss, inhibited osteoclast differentiation | Phytoestrogens | ||
| (143) | Slowing down bone resorption, increased osteoblastic activity | Rutin | ||
| (5) | Inhibited osteoclasts activity | Gamma-L-glutamyl-trans-S-1-propenyl-L-cysteine sulfoxide | Clin. | |
| (46) | Decreased hip fracture | Vitamin K | ||
| (156) | Decreased systolic blood pressure | Aqueous extract of onion | Exper. | Cardiovascular system |
| (160) | Vasodilation | Raw green-leaf extract of onion | ||
| (165) | Decreased high blood pressure and cardiac hypertrophy, increased nitric oxide availability | Quercetin | ||
| (162, 163) | Decreased myocardial infarction incidence, protected the initiation and progression of atherosclerosis | Flavonoids | Clin. | |
| (164) | Decreased coronary heart disease incidence | Isoflavones | ||
The effects of A. cepa (onion) and its constituents on gastrointestinal and nervous systems
| Ref. | Effect | Extract/ | Experimental model | |
| (174) | Decreased food transit time in gastrointestinal system | Onion | Exper. | Gastrointestinal system |
| (123) | Decreased aspartate aminotransferase, alanine aminotransferase and lactate dehydrogenase activities | Onion juice | ||
| (40, 175) | Stimulated growth of useful microorganisms in the colon | Fructans | ||
| (176) | Anti-spasmodic and anti-diarrheal effects | Flavonoids | ||
| (177) | Anti-ulcer effect | Quercetin | ||
| (178) | Increased the amount of gastric mucus, decrease of gastric lesions | Quercetin | ||
| (182) | Improved memory and behavioral deficits, motor incoordination and short-term memory | Onion | Exper. | Nervous system |
| (5, 182) | Decreased cerebral infarct size and improved motor incoordination and short-term memory | Methanol extract of onion | ||
The effects of A. cepa (onion) and its constituents on respiratory and urogenital systems
| Ref. | Effect | Extract/ | Experimental model | |
|---|---|---|---|---|
| (189) | Anti-asthma effects | Thiosulfinates and cepaenes | Exper. | Respiratory system |
| (190) | Decreased bronchial obstruction | Alcoholic extract of onion | ||
| (44) | Decreased cellular infiltration (eosinophil and lymphocyte) and lung inflammation | Aqueous extract of onion | ||
| (191) | Relaxation of tracheal smooth muscle | Methanolic extract of onion | ||
| (193) | decreased immunological markers interleukin-4 and immunoglobulin E, increased interferon-γ | Onion | ||
| (199) | Inhibited interleukin-4 production | Flavonoids | ||
| (203) | Prevented mast cell and basophil degranulation | Quercetin | ||
| (203) | Prevented histamine secretion | Vitamin C | ||
| (206) | Decreased airway hyperreactivity | Quercetin | ||
| (207) | Anti-allergic effects | Kaempferol | ||
| (208) | Improved T helper 1/T helper 2 balance, suppression immunoglobulin E formation | Resveratrol | ||
| (200) | Anti-asthma effects | Flavonoids | Clin. | |
| (203) | Inhibited histamine release | Quercetin | ||
| (203) | Decreased nasal secretions and edema | Vitamin C | ||
| (23, 44) | Improved testes weight, increased serum testosterone levels, sperm count, viability and motility | Juice of onion bulbs | Exper. | Urogenital system |
| (210) | Decreased cellular proliferation, inflammation and apoptosis in atypical prostatic hyperplasia | Methanolic extract | ||
| (24) | Decreased serum creatinine level, protected kidneys from oxidative stress | Onion | ||
| (123) | Decreased serum urea and creatinine levels | Onion juice | ||
| (5) | Increased libido and strengthening reproductive organs against sexual impotence | Onion | Clin. | |
| (216) | Improved non-bacterial chronic prostatitis and prostodynia | Quercetin | ||
| (5) | Diuretic effect | Onion | ||
| (5) | Extraction of renal stones | Syrup of onion | ||
Conclusion
This review showed a wide spectrum effects of A. cepa or onion and its constituents on different disorders both in experimental and clinical studies. Regarding the anti-cancer effects of the plant and its constituents, chemo-preventive and inhibitory effects of the plant on all stages of skin tumorigenesis, inhibitory potential of quercetin on metastatic and growth of melanoma, growth and proliferation of cancer cell lines and its effects of increased intestinal absorption and decreased the first-pass metabolism of tamoxifen were shown in experimental studies. In other experimental studies, the inhibitory effects of the proliferation of several cancer cell lines, the formation of DNA adducts, an increase of glutathione S-transferase activity, a decrease of the number of aberrant crypt foci (precursors of colon cancers) and prevention of radio-resistance following radiotherapy were also indicated for other constituents of the plant. In addition, the reduction effects of onion on the brain cancer risk and decrease of the lung cancer risk for its flavonoids were reported in clinical studies.
The reduction effects of onion and its components, mainly quercetin, on blood glucose levels and dietary glucose absorption and increase of serum insulin levels, as well as protection of pancreatic islets, were demonstrated in experimental studies. In clinical trials, also the reduction effects of onion on blood glucose levels were seen.
The inhibitory effects of onion and its constituents, such as organosulfur components and quercetin on platelet aggregation and TXB2 synthesis, were indicated in experimental studies. The inhibitory effects of the plant on platelet aggregation and suppression of the formation of all oxygenase products were also documented in clinical studies.
In experimental studies, the inhibitory effects of the plant and its components such as quercetin and rutin on bone resorption, osteoclastogenesis as well as osteoclast formation and activity, increase of total bone mineral content and osteoblastic activity, a decrease of bone loss were reported. In clinical studies, the inhibitory effects of onion on osteoclasts activity and decreased hip fracture for vitamin K were demonstrated.
In the cardiovascular system, the reduction effects of onion on high blood pressure and cardiac hypertrophy, vasodilation and increased nitric oxide availability for quercetin in experimental research were seen. The flavonoids of the plant also showed decrease incidence in myocardial infarction and coronary heart disease and protection of the initiation and progression of atherosclerosis in clinical trials.
On gastrointestinal system, decreases in food transit time in the gastrointestinal system as well as aspartate aminotransferase, alanine aminotransferase and lactate dehydrogenase activities were shown for onion and increased growth of useful microorganisms in the colon, anti-spasmodic, anti-diarrheal and anti-ulcer effects, increased amount of gastric mucus and decreased gastric lesions were shown for the plant ingredients mainly quercetin.
Onion also improved the memory and behavioral deficits, motor incoordination and short-term memory and decreased cerebral infarct size.
The anti-asthmatic effects and relaxation of tracheal smooth muscle, a decrease of cellular infiltration (e.g. eosinophil and lymphocyte) and lung inflammation as well as reduction of immunological markers such as IL-4 and IgE and increase of IFN-γ were reported for onion in experimental studies. The constituents of the plant also showed inhibitory effects on IL-4 production, IgE formation, mast cell and basophil degranulation, histamine secretion and airway hyperreactivity as well as improvement of Th1/Th2 balance and anti-allergic effects. In clinical trials, the plant constituents showed anti-asthmatic activities, inhibition of histamine release and decreases in nasal secretions and edema.
In the urogenital system, onion also showed improvement of testes weight, increases in serum testosterone levels, sperm count, viability and motility, decreases in cellular proliferation, inflammation and apoptosis in atypical prostatic hyperplasia, reduction of serum creatinine levels and protection of kidneys from oxidative stress in experimental studies. In clinical studies, onion also showed increased libido and strengthening reproductive organs against sexual impotence, improved non-bacterial chronic prostatitis and prostodynia, diuretic effects and extraction of renal stones.
Therefore, a wide range of pharmacological effects was reported for onion in the published studies, mainly in experimental studies. However, more clinical trials are needed regarding the effects of the plant and its constituents before they could be used in clinical practice.
References
-
1.
Akash MSH, Rehman K, Chen S. Spice plant Allium cepa: Dietary supplement for treatment of type 2 diabetes mellitus. Nutrition. 2014;30:1128-37. [PubMed ID: 25194613].
-
2.
Bisen P, Emerald M. Nutritional and therapeutic potential of garlic and onion (Allium sp ). Curr. Nutr. Food Sci. 2016;12:190-9.
-
3.
Dhawan B. WHO monographs on selected medicinal plants. USA: World Health Organization;
-
4.
Stajner D, Varga IS. An evaluation of the antioxidant abilities of Allium species. Acta Biologica. 2003;47:103-6.
-
5.
Ashwini M, Sathishkumar R. 3. Onion (Allium cepa)-Ethnomedicinal and therapeutic properties. Handbook of Medicinal plants and their Bioactive compounds. 2014. p. 27-34.
-
6.
Albishi T, John JA, Al-Khalifa A, Shahidi F. Antioxidative phenolic constituents of skins of onion varieties and their activities. J. Funct. Foods. 2013;5:1191-203.
-
7.
Shahidi F. Maximising the value of marine by-products. Woodhead Publishing; 2006.
-
8.
Lanzotti V. The analysis of onion and garlic. J. Chromatogr. A. 2006;1112:3-22. [PubMed ID: 16388813].
-
9.
Bouba AA, Njintang NY, Nkouam GB, Mang YD, El-Sayed Mehanni AH, Scher J, Montet D, Mbofung CM. Desorption isotherms, net isosteric heat and the effect of temperature and water activity on the antioxidant activity of two varieties of onion (A llium cepa L). Int. J. Food Sci. Technol. 2014;49:444-52.
-
10.
Azad TT, Hosein M, Haque S, Ahmed I, Afsana NA, Basher A. A pharmacological study on antinociceptive and antihyperglycemic effects of Allium cepa leaves in Swiss albino mice. ANAS. 2014;8:330-8.
-
11.
Bystricka J, Musilova J, Vollmannova A, Timoracka M, Kavalcova P. Bioactive components of onion (Allium cepa L )-a Review. Acta Aliment. 2013;42:11-22.
-
12.
Dawud FA, Dubo AB, Yusuf NW, Umar IA. Effects of aqueous extract of Allium cepa (red onion) on ovalbumin induced allergic asthma in wistar rats. BAJOPAS. 2016;9:95-101.
-
13.
Venkatesh V, Sharma J, Kamal R. A comparative study of effect of alcoholic extracts of Sapindus emarginatus, Terminalia belerica, Cuminum cyminum and Allium cepa on reproductive organs of male albino rats. Asian. J. Exp. Sci. 2002;16:51-63.
-
14.
Jamshid G. Androgenic effect of onion (Allium cepa linn) aqueous extract on sperms quantity and viability compared with Zn sulfate supplementation in the rats. Asian. J. Exp. Biol. Sci. 2012;3:2012.
-
15.
Srivastava K. Aqueous extracts of onion, garlic and ginger inhibit platelet aggregation and alter arachidonic acid metabolism. Biomed. Biochim. Acta. 1984;43:335-46.
-
16.
Goldman IL, Kopelberg M, Debaene JE, Schwartz BS. Antiplatelet activity in onion (Allium cepa) is sulfur dependent. J. Thromb. Haemost. 1996;76:450-2.
-
17.
Moon CH, Jung YS, Kim MH, Lee SH, Baik EJ, Park SW. Mechanism for antiplatelet effect of onion: AA release inhibition, thromboxane A2 synthase inhibition and TXA2/PGH2 receptor blockade. Prostaglandins. Leukot. Essent. Fatty. Acids. 2000;62:277-83. [PubMed ID: 10883058].
-
18.
Ogunmodede OS, Saalu LC, Ogunlade B, Akunna GG, Oyewopo AO. An evaluation of the hypoglycemic, antioxidant and hepatoprotective potentials of onion (Allium cepa L ) on alloxan-induced diabetic rabbits. Int. J. Pharmacol. 2012;8:21-9.
-
19.
Shri R, Bora KS. Neuroprotective effect of methanolic extracts of Allium cepa on ischemia and reperfusion-induced cerebral injury. Fitoterapia. 2008:79 86-96. [PubMed ID: 17850989].
-
20.
Kumar A, Bora KS, Jaggi AS, Shri R. Comparative evaluation of neuroprotective effect of three varieties of Allium cepa in chronic constriction injury induced neuropathic pain. Thai J. Pharm. Sci. 2016;40:9-20.
-
21.
Pitchaiah G, Anusha VL, Hemalatha CH, Kumar A, Sravani K. Anxiolytic and anticonvulsant activity of methanolic extract of allium cepa Linn (Onion) bulbs in Swiss albino mice. Phytochemistry. 2015;4:131-5.
-
22.
Sakakibara H, Yoshino S, Kawai Y, Terao J. Antidepressant-like effect of onion (Allium cepa L ) powder in a rat behavioral model of depression. Biosci. Biotechnol. Biochem. 2008;72:94-100. [PubMed ID: 18175926].
-
23.
Ekaluo UB, Uno UU, Edu NE, Ekpo PB, Etta SE, Volunteer BO. Protective role of onion (Allium cepa L ) on caffeine induces spermatotoxicity in albino rats. J. Appl. Life Sci. Int. 2016;4:1-7.
-
24.
Chinnala KM, Achanta P, Vangala VL, Elsani MM. Evaluation for nephroprotective activity of ethanolic extract of allium cepa linn in gentamicin-induced nephrotoxicity in rats. Asian. J. Pharm. Clin. Res. 2017;10:356-9.
-
25.
Ozougwa J, Eyo J. Hepatoprotective effects of Allium cepa (onion) extracts against paracetamol-induced liver damage in rats. J. Biotechnol. 2014;13:2679-88.
-
26.
Albishi T, John JA, Al-Khalifa AS, Shahidi F. Antioxidant, anti-inflammatory and DNA scission inhibitory activities of phenolic compounds in selected onion and potato varieties. J. Funct. Foods. 2013;5:930-9.
-
27.
Takahashi M, Shibamoto T. Chemical compositions and antioxidant/anti-inflammatory activities of steam distillate from freeze-dried onion (Allium cepa L ) sprout. J. Agric. Food Chem. 2008;56:10462-7. [PubMed ID: 18942842].
-
28.
Lee KA, Kim KT, Kim HJ, Chung MS, Chang PS, Park H, Pai HD. Antioxidant activities of onion (Allium cepa L ) peel extracts produced by ethanol, hot water, and subcritical water extraction. Food Sci. Biotechnol. 2014;23:615-21.
-
29.
Kaiser P, Youssouf MS, Tasduq SA, Singh S, Sharma SC, Singh GD, Gupta VK, Gupta BD, Johri RK. Anti-allergic effects of herbal product from Allium cepa (bulb). J. Med. Food. 2009;12:374-82. [PubMed ID: 19459740].
-
30.
Dorsch W, Wagner H, Bayer T, Fessler B, Hein G, Ring J, Scheftner P, Sieber W, Strasser T, Weiss E. Anti-asthmatic effects of onions: Alk (en) ylsulfinothioic acid alk (en) yl-esters inhibit histamine release, leukotriene and thromboxane biosynthesis in-vitro and counteract paf and allergen-induced bronchial obstruction in vivo. Biochem. Pharmacol. 1988;37:4479-86. [PubMed ID: 2462422].
-
31.
Chisty MM, Quddus R, Islam B, Khan BR. Effect of onion extract on immune response in rabbits. Bangladesh. Med. Res. Counc. Bull. 1996;22:81-5. [PubMed ID: 9103661].
-
32.
New SA, Robins SP, Campbell MK, Martin JC, Garton MJ, Bolton-Smith C, Grubb DA, Lee SJ, Reid DM. Dietary influences on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health? Am. J. Clin. Nutr. 2000;71:142-51.
-
33.
Dorant EV, van den Brandt PA, Goldbohm RA, Sturmans FE. Consumption of onions and a reduced risk of stomach carcinoma. Gastroenterology. 1996;110:12-20. [PubMed ID: 8536847].
-
34.
Nile S H, Park S W. Total phenolics, antioxidant and xanthine oxidase inhibitory activity of three colored onions (Allium cepa L ). Front. Life. Sci. 2013;7:224-228.
-
35.
Corzo-Martínez M, Corzo N, Villamiel M. Biological properties of onions and garlic. Trends. Food Sci. Technol. 2007;18:609-25.
-
36.
Benmalek Y, Yahia OA, Belkebir A, Fardeau ML. Anti-microbial and antioxidant activities of Illicium verum, Crataegus oxyacantha ssp monogyna and Allium cepa red and white varieties. Bioengineered. 2013;4:244-8. [PubMed ID: 23579100].
-
37.
Marefati N, Ghorani V, Shakeri F, Boskabady M, Kianian F, Rezaee R, Boskabady MH. A review of anti-inflammatory, antioxidant, and immunomodulatory effects of Allium cepa and its main constituents. Pharm Biol. 2021;59:287-302. [PubMed ID: 33645419].
-
38.
Yamamoto Y, Yasuoka A. Welsh onion attenuates hyperlipidemia in rats fed on high-fat high-sucrose diet. Biosci. Biotechnol. Biochem. 2010;74:402-4. [PubMed ID: 20139615].
-
39.
Rhodes MJ, Price K R. Analytical problems in the study of flavonoid compounds in onions. Food Chem. 1996;57:113-7.
-
40.
Ernst M, Feldheim W. Fructans in higher plants and in human nutrition. J. Appl. Botany. 2000;74:5-9.
-
41.
Dorsch W, Schneider E, Bayer T, Breu W, Wagner H. Anti-inflammatory effects of onions: inhibition of chemotaxis of human polymorphonuclear leukocytes by thiosulfinates and cepaenes. Int. Arch. Allergy Immunol. 1990;92:39-42.
-
42.
Griffiths G, Trueman L, Crowther T, Thomas B, Smith B. Onions-a global benefit to health. Phytother. Res. 2002:16 603-615.
-
43.
Augusti K. Therapeutic values of onion (Allium cepa ) and garlic (Allium sativum L ). Indian. J. Exp. Biol. 1996;34:634-40. [PubMed ID: 8979497].
-
44.
Khaki A, Fathiazad F, Nouri M, Khaki AA, Khamenehi HJ, Hamadeh M. Evaluation of androgenic activity of allium cepa on spermatogenesis in the rat. Folia Morphol. 2009;68:45-51.
-
45.
Kuhnau J. The flavonoids A class of semi-essential food components: their role in human nutrition. World Rev. Nutr. Diet. 1976;24:117-91. [PubMed ID: 790781].
-
46.
Feskanich D, Weber P, Willett WC, Rockett H, Booth SL, Colditz GA. Vitamin K intake and hip fractures in women: a prospective study. Am. J. Clin. Nutr. 1999;69:74-9. [PubMed ID: 9925126].
-
47.
Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P, Kukreja SC. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J. Nutr. 1996;126:161-7. [PubMed ID: 8558297].
-
48.
Tobe H, Muraki Y, Kitamura K, Komiyama O, Sato Y, Sugioka T, Maruyama HB, Matsuda E, Nagai M. Bone resorption inhibitors from hop extract. Biosci. Biotechnol. Biochem. 1997;61:158-9. [PubMed ID: 9028043].
-
49.
Wiczkowski W, Romaszko J, Bucinski A, Szawara-Nowak D, Honke J, Zielinski H, Piskula MK. Quercetin from shallots (Allium cepa L var aggregatum) is more bioavailable than its glucosides. J. Nutr. 2008;138:885-8. [PubMed ID: 18424596].
-
50.
Ohsumi C, Hayashi T, Kubota K, Kobayashi A. Volatile flavor compounds formed in an interspecific hybrid between onion and garlic. J. Agric. Food Chem. 1993;41:1808-10.
-
51.
Galeone C, Pelucchi C, Levi F, Negri E, Franceschi S, Talamini R, Attilio Giacosa, Carlo La Vecchia. Onion and garlic use and human cancer. Am. J. Clin. Nutr. 2006;84:1027-32. [PubMed ID: 17093154].
-
52.
Guercio V, Galeone C, Turati F, La Vecchia C. Gastric cancer and allium vegetable intake: a critical review of the experimental and epidemiologic evidence. Nutr. Cancer. 2014;66:757-73. [PubMed ID: 24820444].
-
53.
Wang Y, Tian W-X, Ma X-F. Inhibitory effects of onion (Allium cepa L ) extract on proliferation of cancer cells and adipocytes via inhibiting fatty acid synthase. Asian. Pac. J. Cancer Prev. 2012;13:5573-9. [PubMed ID: 23317220].
-
54.
Block E. The chemistry of garlic and onions. Sci. Am. 1985;252:114-9. [PubMed ID: 3975593].
-
55.
Moriarty RM, Naithani R, Surve B. Organosulfur compounds in cancer chemoprevention. Mini Rev. Med. Chem. 2007;7:827-38. [PubMed ID: 17692044].
-
56.
Fukushima S, Takada N, Hori T, Wanibuchi H. Cancer prevention by organosulfur compounds from garlic and onion. J. Cell. Biochem. 1997;67:100-5.
-
57.
Le Bon A-M, Siess M-H. Organosulfur compounds from Allium and the chemoprevention of cancer. Drug. Metabol. Drug. Interact. 2000;17:51-80. [PubMed ID: 11201304].
-
58.
Scherer C, Jacob C, Dicato M, Diederich M. Potential role of organic sulfur compounds from Allium species in cancer prevention and therapy. Phytochem. Rev. 2009;8:349.
-
59.
Guyonnet D, Belloir C, Suschetet M, Siess M-H, Le Bon A-M. Antimutagenic activity of organosulfur compounds from Allium is associated with phase II enzyme induction. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 2001;495:135-45.
-
60.
Shon MY, Choi SD, Kahng GG, Nam SH, Sung NJ. Antimutagenic, antioxidant and free radical scavenging activity of ethyl acetate extracts from white, yellow and red onions. Food Chem. Toxicol. 2004;42:659-66. [PubMed ID: 15019191].
-
61.
Ip C, Lisk DJ. Enrichment of selenium in allium vegetables for cancer prevention. Carcinogenesis. 1994;15:1881-5. [PubMed ID: 7923581].
-
62.
Ip C, Lisk DJ. Characterization of tissue selenium profiles and anticarcinogenic responses in rats fed natural sources of selenium-rich products. Carcinogenesis. 1994;15:573-6. [PubMed ID: 8149465].
-
63.
Varadkar P, Dubey P, Krishna M, Verma NC. Modulation of radiation-induced protein kinase C activity by phenolics. J. Radiol. Prot. 2001;21:361-70. [PubMed ID: 11787891].
-
64.
Shin S-C, Choi J-S, Li X. Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats. Int. J. Pharm. 2006;313:144-9. [PubMed ID: 16516418].
-
65.
Wu CP, Calcagno AM, Hladky SB, Ambudkar SV, Barrand MA. Modulatory effects of plant phenols on human multidrug-resistance proteins 1, 4 and 5 (ABCC1, 4 and 5). FEBS J. 2005;272:4725-40. [PubMed ID: 16156793].
-
66.
Fukao T, Hosono T, Misawa S, Seki T, Ariga T. The effects of allyl sulfides on the induction of phase II detoxification enzymes and liver injury by carbon tetrachloride. Food Chem. Toxicol. 2004;42:743-9. [PubMed ID: 15046820].
-
67.
Guyonnet D, Siess MH, Le Bon AM, Suschetet M. Modulation of phase II enzymes by organosulfur compounds from allium vegetables in rat tissues. Toxicol. Appl. Pharmacol. 1999;154:50-8. [PubMed ID: 9882591].
-
68.
Haber-Mignard D, Suschetet M, Bergès R, Astorg P, Siess MH. Inhibition of aflatoxin B1-and N-nitrosodiethylamine-induced liver preneoplastic foci in rats fed naturally occurring allyl sulfides. Nutr. Cancer. 1996;25:61-70. [PubMed ID: 8837862].
-
69.
Herman-Antosiewicz A, Singh SV. Signal transduction pathways leading to cell cycle arrest and apoptosis induction in cancer cells by Allium vegetable-derived organosulfur compounds: a review. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 2004;555:121-31.
-
70.
Ziegler D. Role of reversible oxidation-reduction of enzyme thiols-disulfides in metabolic regulation. Annu. Rev. Biochem. 1985;54:305-29. [PubMed ID: 2862840].
-
71.
Ban JO, Hwang IG, Kim TM, Hwang BY, Lee US, Jeong HS, Yoon YW, Kim DJ, Hong JT. Anti-proliferate and pro-apoptotic effects of 2, 3-dihydro-3, 5-dihydroxy-6-methyl-4H-pyranone through inactivation of NF-κB in human colon cancer cells. Arch. Pharm. Res. 2007;30:1455. [PubMed ID: 18087815].
-
72.
Perchellet J, Perchellet E, Abney N, Zirnstein J, Belman S. Effects of garlic and onion oils on glutathione peroxidase activity, the ratio of reduced/oxidized glutathione and ornithine decarboxylase induction in isolated mouse epidermal cells treated with tumor promoters. Cancer Biochem. Biophys. 1986;8:299-312. [PubMed ID: 3802049].
-
73.
Arora A, Seth K, Shukla Y. Reversal of P-glycoprotein-mediated multidrug resistance by diallyl sulfide in K562 leukemic cells and in mouse liver. Carcinogenesis. 2004;25:941-9. [PubMed ID: 14729595].
-
74.
Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. 1999;39:361-98. [PubMed ID: 10331089].
-
75.
Powolny AA, Singh SV. Multitargeted prevention and therapy of cancer by diallyl trisulfide and related Allium vegetable-derived organosulfur compounds. Cancer Lett. 2008;269:305-14. [PubMed ID: 18579286].
-
76.
Lee HN, Shin SA, Choo GS, Kim HJ, Park YS, Kim SK, Jung JY. Inhibitory effects of spinach, cabbage, and onion extracts on growth of cancer cells. J. Korean. Soc. Food Sci. Nutr. 2016;45:671-9.
-
77.
Shrivastava S, Ganesh N. Tumor inhibition and cytotoxicity assay by aqueous extract of onion (Allium cepa) & Garlic (Allium sativum): an in-vitro analysis. Phytomedicine. 2010:2. [PubMed ID: 21036575].
-
78.
Xu B, Sung C. Telomerase inhibitory effects and anti-proliferative properties of onion and other natural spices against cancer cells. Food Biosci. 2015;10:80-5.
-
79.
Han MH, Lee WS, Jung JH, Jeong JH, Park C, Kim HJ, Kim G, Jung JM, Kwon TK, Kim GY, Ryu CH. Polyphenols isolated from Allium cepa induces apoptosis by suppressing IAP-1 through inhibiting PI3K/Akt signaling pathways in human leukemic cells. Food Chem. Toxicol. 2013;62:382-9. [PubMed ID: 24021570].
-
80.
Choi JA, Kim JY, Lee JY, Kang CM, Kwon HJ, Yoo YD, Kim TW, Lee YS, Lee SJ. Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. Int. J. Oncol. 2001;19:837-44. [PubMed ID: 11562764].
-
81.
Scambia G, Mancuso S, Panici PB, De Vincenzo R, Ferrandina G, Bonanno G, Ranelletti FO, Piantelli M, Capelli A. Quercetin induces type-II estrogen-binding sites in estrogen-receptor-negative (MDA-MB231) and estrogen-receptor-positive (MCF-7) human breast-cancer cell lines. Int. J. Cancer. 1993;54:462-6. [PubMed ID: 8509221].
-
82.
Larocca LM, Teofili L, Sica S, Piantelli M, Maggiano N, Leone G, Ranelletti FO. Quercetin inhibits the growth of leukemic progenitors and induces the expression of transforming growth factor-beta 1 in these cells. Blood. 1995;85:3654-61. [PubMed ID: 7780149].
-
83.
Singhal RL, Yeh YA, Prajda N, Olah E, Sledge G, Weber G. Quercetin down-regulates signal transduction in human breast carcinoma cells. Biochem. Biophys. Res. Commun. 1995;208:425-31. [PubMed ID: 7887960].
-
84.
Larocca LM, Teofili L, Leone G, Sica S, Pierelli L, Menichella G, Scambia G, Panici PB, Ricci R, Piantelli M, Ranelletti FO. Antiproliferative activity of quercetin on normal bone marrow and leukaemic progenitors. Br. J. Haematol. 1991;79:562-6. [PubMed ID: 1772777].
-
85.
Pereira MA, Grubbs CJ, Barnes LH, Li H, Olson GR, Eto I, Juliana M, Whitaker LM, Kelloff GJ, Steele VE, Lubet RA. Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7, 12-dimethylbenz [a] anthracene-induced mammary cancer in rats. Carcinogenesis . 1996;17:1305-11. [PubMed ID: 8681447].
-
86.
Castillo MH, Perkins E, Campbell JH, Doerr R, Hassett JM, Kandaswami C, Middleton E. The effects of the bioflavonoid quercetin on squamous cell carcinoma of head and neck origin. Am. J. Surg. 1989;158:351-5. [PubMed ID: 2802040].
-
87.
Scambia G, Ranelletti FO, Benedetti PP, Bonanno G, De RV, Piantelli M, Mancuso S. Synergistic antiproliferative activity of quercetin and cisplatin on ovarian cancer cell growth. Anticancer. Drugs. 1990;1:45-8. [PubMed ID: 2131036].
-
88.
Galeone C, Pelucchi C, Dal Maso L, Negri E, Montella M, Zucchetto A, Talamini R, La Vecchia C. Allium vegetables intake and endometrial cancer risk. Public. Health. Nutr. 2009;12:1576-9. [PubMed ID: 18986589].
-
89.
Yoshida M, Sakai T, Hosokawa N, Marui N, Matsumoto K, Fujioka A, Nishino H, Aoike A. The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett. 1990;260:10-3. [PubMed ID: 2298289].
-
90.
Caltagirone S, Ranelletti FO, Rinelli A, Maggiano N, Colasante A, Musiani P, Aiello FB, Piantelli M. Interaction with type II estrogen binding sites and antiproliferative activity of tamoxifen and quercetin in human non-small-cell lung cancer. Am. J. Respir. Cell Mol. Biol. 1997;17:51-9. [PubMed ID: 9224209].
-
91.
Avila MA, Cansado J, Harter KW, Velasco JA, Notario V. Quercetin as a modulator of the cellular neoplastic phenotype. Dietary Phytochemicals in Cancer Prevention and Treatment: Springer. 1996:101-10.
-
92.
Avila MA, Velasco JA, Cansado J, Notario V. Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468. Cancer Res. 1994;54:2424-8. [PubMed ID: 8162591].
-
93.
Sakamoto K, Lavvson L, Milner J. Allyl sulfides from garlic suppress the in-vitro proliferation of human A549 lung tumor cells. Nutrl. Cancer. 1997;29:152-6.
-
94.
Shukla Y, Arora A, Singh A. Antitumorigenic potential of diallyl sulfide in Ehrlich ascites tumor bearing mice. Biomed. Environ. Sci. 2002;15:41-7. [PubMed ID: 12046547].
-
95.
Sigounas G, Hooker J, Anagnostou A, Steiner M. S-allylmercaptocysteine inhibits cell proliferation and reduces the viability of erythroleukemia, breast, and prostate cancer cell lines. Nutr. Cancer. 1997;27:186-91. [PubMed ID: 9121948].
-
96.
Knowles LM, Milner JA. Depressed p34 cdc2 kinase Activity and G2/M phase arrest induced by diallyl disulfide in HCT-15 cells. Nutr. Cancer. 1998;30:169-74. [PubMed ID: 9631486].
-
97.
Challier B, Perarnau J-M, Viel J-F. Garlic, onion and cereal fibre as protective factors for breast cancer: a French case–control study. Eur. J. Epidemiol. 1998;14:737-47. [PubMed ID: 9928867].
-
98.
Hu J, La Vecchia C, Negri E, Chatenoud L, Bosetti C, Jia X, Liu R, Huang G, Bi D, Wang C. Diet and brain cancer in adults: A case-control study in Northeast China. Int. J. Cancer. 1999;81:20-3. [PubMed ID: 10077146].
-
99.
Haenszel W, Kurihara M, Segi M, Lee RK. Stomach cancer among Japanese in Hawaii. J. Natl. Cancer Inst. 1972;49:969-88. [PubMed ID: 4678140].
-
100.
Prostate Lung. Colorectal and Ovarian (PLCO) Cancer Screening Trial Project Team Fruit and vegetable intake and prevalence of colorectal adenoma in a cancer screening trial. Am. J. Clin. Nutr. 2007;86:1754-64. [PubMed ID: 18065596].
-
101.
Chen YK, Lee CH, Wu IC, Liu JS, Wu DC, Lee JM, Goan YG, Chou SH, Huang CT, Lee CY, Hung HC. Food intake and the occurrence of squamous cell carcinoma in different sections of the esophagus in Taiwanese men. Nutrition. 2009;25:753-61. [PubMed ID: 19394796].
-
102.
Le Marchand L, Murphy SP, Hankin JH, Wilkens LR, Kolonel LN. Intake of flavonoids and lung cancer. J. Natl. Cancer Inst. 2000;92:154-60. [PubMed ID: 10639518].
-
103.
Chan JM, Wang F, Holly EA. Vegetable and fruit intake and pancreatic cancer in a population-based case-control study in the San Francisco bay area. Biomarkers. 2005;14:2093-7.
-
104.
Hsing AW, Chokkalingam AP, Gao YT, Madigan MP, Deng J, Gridley G, Fraumeni Jr JF. Allium vegetables and risk of prostate cancer: a population-based study. J. Natl. Cancer Inst. 2002;94:1648-51. [PubMed ID: 12419792].
-
105.
He Y, Jin H, Gong W, Zhang C, Zhou A. Effect of onion flavonoids on colorectal cancer with hyperlipidemia: an in-vivo study. Onco. Targets Ther. 2014;7:101-110. [PubMed ID: 24470761].
-
106.
Davis W, Lamson M, Matthew S, Brignall N. Antioxidants and cancer III: quercetin. Altern. Med. Rev. 2000;5:196-208. [PubMed ID: 10869101].
-
107.
Molnar J, Beladi I, Domonkos K, Földeák S, Boda K, Veckenstedt A. Antitumor activity of flavonoids on NK/Ly ascites tumor cells. Neoplasma. 1981;28:11-8. [PubMed ID: 7279054].
-
108.
Sparnins VL, Barany G, Wattenberg LW. Effects of organosulfur compounds from garlic and onions on benzo [a] pyrene-induced neoplasia and glutathione S-transferase activity in the mouse. Carcinogenesis. 1988;9:131-4. [PubMed ID: 3335037].
-
109.
Zhang Zm, Yang Xy, Deng Sh, Wei X, Gao Hq. Anti-tumor effects of polybutylcyanoacrylate nanoparticles of diallyl trisulfide on orthotopic transplantation tumor model of hepatocellular carcinoma in BALB/c nude mice. Zhonghua. Yi. Xue. Za. Zhi. 2007;120:1336-42.
-
110.
Singh A, Shukla Y. Antitumour activity of diallyl sulfide on polycyclic aromatic hydrocarbon-induced mouse skin carcinogenesis. Cancer Lett. 1998;131:209-14. [PubMed ID: 9851255].
-
111.
Tsuda H, Uehara N, Iwahori Y, Asamoto M, Ligo M, Nagao M, Matsumoto K, Ito M, Hirono I. Chemopreventive Effects of β-Carotene, α-Tocopherol and Five Naturally Occurring Antioxidants on Initiation of Hepatocarcinogenesis by 2-Amino-3-methylimidazo [4, 5-f] qumoline in the Rat. Jpn. J. Cancer Res. 1994;85:1214-9. [PubMed ID: 7852184].
-
112.
Fattorusso E, Lanzotti V, Taglialatela-Scafati O, Di Rosa M, Ianaro A. Cytotoxic saponins from bulbs of Allium porrum L. J. Agric. Food Chem. 2000;48:3455-62. [PubMed ID: 10956133].
-
113.
Carotenuto A, Fattorusso E, Lanzotti V, Magno S, Carnuccio R, D’Acquisto F. 12-Keto-porrigenin and the unique 2, 3-seco-porrigenin, new antiproliferative sapogenins from Allium porrum. Tetrahedron. 1997;53:3401-6.
-
114.
El-Soud N, Khalil M. Antioxidative effects of Allium cepa essential oil in streptozotocin induced diabetic rats. Maced. J. Med. Sci. 2010;3:344-51.
-
115.
Kendler BS. Garlic (Allium sativum) and onion (Allium cepa): a review of their relationship to cardiovascular disease. Prev. Med. 1987;16:670-85. [PubMed ID: 3317392].
-
116.
Babu PS, Srinivasan K. Influence of dietary capsaicin and onion on the metabolic abnormalities associated with streptozotocin induced diabetes mellitus. Mol. Cell. Biochem. 1997;175:49-57. [PubMed ID: 9350033].
-
117.
Jain R, Sachdev K. A note on hypoglycemic action of onion in diabetes. Curr. Med. Pract. 1971;15:901-2.
-
118.
Tjokroprawiro A, Pikir BS, Budhiarta AA, Soewondo H, Donosepoetro M, Budhianto FX, Wibowo JA, Tanuwidjaja SJ, Pangemanan M, Widodo H, Surjadhana A. Metabolic effects of onion and green beans on diabetic patients. Tohoku. J. Exp. Med. 1983;141:671-6. [PubMed ID: 6393443].
-
119.
Abouzed TK, del Mar Contreras M, Sadek KM, Shukry M, Abdelhady DH, Gouda WM, Abdo W, Nasr NE, Mekky RH, Segura-Carretero A, Kahilo KA. Red onion scales ameliorated streptozotocin-induced diabetes and diabetic nephropathy in Wistar rats in relation to their metabolite fingerprint. Diabetes. Res. Clin. Pract. 2018;140:253-64. [PubMed ID: 29626589].
-
120.
Eldin IMT, Ahmed EM, Abd EH. Preliminary study of the clinical hypoglycemic effects of Allium cepa (red onion) in type 1 and type 2 diabetic patients. Environ. Health. Insights. 2010;4:71-7. [PubMed ID: 21079693].
-
121.
Pradeep SR, Srinivasan K. Alleviation of Cardiac Damage by Dietary Fenugreek (Trigonella foenum-graecum) Seeds is Potentiated by Onion (Allium cepa) in Experimental Diabetic Rats via Blocking Renin–Angiotensin System. Cardiovasc. Toxicol. 2018;18:221-31. [PubMed ID: 29094243].
-
122.
Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes. 1999;48:1-9. [PubMed ID: 9892215].
-
123.
El-Demerdash F, Yousef M, El-Naga NA. Biochemical study on the hypoglycemic effects of onion and garlic in alloxan-induced diabetic rats. Food Chem. Toxicol. 2005;43:57-63. [PubMed ID: 15582196].
-
124.
Campos KE, Diniz YS, Cataneo AC, Faine LA, Alves MJ, Novelli EL. Hypoglycaemic and antioxidant effects of onion, Allium cepa: dietary onion addition, antioxidant activity and hypoglycaemic effects on diabetic rats. Int. J. Food Sci. Nutr. 2003;54:241-6. [PubMed ID: 12775373].
-
125.
Dwivedi C, Daspaul S. Antidiabetic herbal drugs and polyherbal formulation used for diabetes: A review. J. Phytopharmacol. 2013;2:44-51.
-
126.
Srinivasan K. Plant foods in the management of diabetes mellitus: spices as beneficial antidiabetic food adjuncts. Int. J. Food Sci. Nutr. 2005;56:399-414. [PubMed ID: 16361181].
-
127.
Sheela C, Kumud K, Augusti K. Anti-diabetic effects of onion and garlic sulfoxide amino acids in rats. Planta. Medica. 1995;61:356-7. [PubMed ID: 7480182].
-
128.
Jo SH, Ka EH, Lee HS. Comparison of antioxidant potential and rat intestinal a-glucosidases inhibitory activities of quercetin, rutin, and isoquercetin. J. Appl. 2009;2:52-60.
-
129.
Kim SH, Jo SH, Kwon YI, Hwang JK. Effects of onion (Allium cepa L ) extract administration on intestinal α-glucosidases activities and spikes in postprandial blood glucose levels in SD rats model. Int. J. Mol. Sci. 2011;12:3757-69. [PubMed ID: 21747704].
-
130.
Khaki A, Fathiazad F, Nouri M, Khaki A, Maleki NA, Khamnei HJ, Ahmadi P. Beneficial effects of quercetin on sperm parameters in streptozotocin-induced diabetic male rats. Phytother. Res. 2010;24:1285-91. [PubMed ID: 20127875].
-
131.
Youl E, Bardy G, Magous R, Cros G, Sejalon F, Virsolvy A, Richard S, Quignard JF, Gross R, Petit P, Bataille D. Quercetin potentiates insulin secretion and protects INS-1 pancreatic β-cells against oxidative damage via the ERK1/2 pathway. Br. J. Pharmacol. 2010;161:799-814. [PubMed ID: 20860660].
-
132.
Vanderhoek JY, Makheja AN, Bailey JM. Inhibition of fatty acid oxygenases by onion and garlic oils: evidence for the mechanism by which these oils inhibit platelet aggregation. Biochem. Pharmacol. 1980;29:3169-73. [PubMed ID: 6778482].
-
133.
Makheja AN, Vanderhoek JY, Bailey JM. Effects of onion (Allium cepa) extract on platelet aggregation and thromboxane synthesis. Prostaglandins. Med. 1979;2:413-24. [PubMed ID: 552092].
-
134.
Mittal MM, Mittal S, Sarin JC, Sharma ML. Effects of feeding onion on fibrinolysis, serum cholesterol, platelet aggregation and adhesion. Indian. J. Med. Sci. 1974;28:144-8. [PubMed ID: 4443004].
-
135.
Makheja A, Bailey J. Antiplatelet constituents of garlic and onion. Agents Action. Suppl. 1990;29:360-3.
-
136.
Phillips C, Poyser N. Inhibition of platelet aggregation by onion extracts. The Lancet. 1978;311:1051-2.
-
137.
Ro JY, Ryu JH, Park HJ, Cho HJ. Onion (Allium cepa L ) peel extract has anti-platelet effects in rat platelets. Springerplus. 2015;4:17. [PubMed ID: 25628983].
-
138.
Suleria HAR, Butt MS, Anjum FM, Saeed F, Khalid N. Onion: Nature protection against physiological threats. Crit. Rev. Food Sci. Nutr. 2015;55:50-66. [PubMed ID: 24915405].
-
139.
Ali M, Thomson M, Afzal M. Garlic and onions: their effect on eicosanoid metabolism and its clinical relevance. PLEFA. 2000;62:55-73.
-
140.
Vilahur G, Badimon L. Antiplatelet properties of natural products. Vascul. Pharmacol. 2013;59:67-75. [PubMed ID: 23994642].
-
141.
Ali M, Bordia T, Mustafa T. Effect of raw versus boiled aqueous extract of garlic and onion on platelet aggregation. Prostaglandins. Leukot. Essent. Fatty. Acids. 1999;60:43-7. [PubMed ID: 10319916].
-
142.
Furusawa M, Tsuchiya H, Nagayama M, Tanaka T, Nakaya KI, Iinuma M. Anti-platelet and membrane-rigidifying flavonoids in brownish scale of onion. Glob. J. Health. Sci. 2003;49:475-80.
-
143.
Horcajada-Molteni MN, Crespy V, Coxam V, Davicco MJ, Remesy C, Barlet JP. Rutin inhibits ovariectomy-induced osteopenia in rats. J. Bone. Miner. Res. 2000;15:2251-8. [PubMed ID: 11092407].
-
144.
Muhlbauer RC, Lozano A, Reinli A. Onion and a mixture of vegetables, salads, and herbs affect bone resorption in the rat by a mechanism independent of their base excess. J. Bone. Miner. Res. 2002;17:1230-6. [PubMed ID: 12096836].
-
145.
Muhlbauer R, Li F, Lozano A, Reinli A, Tschudi I. Some vegetables (commonly consumed by humans) efficiently modulate bone metabolism. J. Musculoskelet. Neuronal. Interact. 2000;1:137-40. [PubMed ID: 15758507].
-
146.
Muhlbauer RC, Lozano A, Reinli A, Wetli H. Various selected vegetables, fruits, mushrooms and red wine residue inhibit bone resorption in rats. J. Nutr. 2003;133:3592-7. [PubMed ID: 14608079].
-
147.
Wetli HA, Brenneisen R, Tschudi I, Langos M, Bigler P, Sprang T, Schürch S, Mühlbauer RC. A γ-glutamyl peptide isolated from onion (Allium cepa L ) by bioassay-guided fractionation inhibits resorption activity of osteoclasts. J. Agric. Food Chem. 2005;53:3408-14. [PubMed ID: 15853380].
-
148.
Langos M, Hofstetter W, Dolder S, Felix R, Mühlbauer R, Brenneisen R. A gamma-glutamyl peptide from onion inhibits the development and activity of osteoclasts in vitro. Planta. Medica. 2007;73:458.
-
149.
Tang C-H, Huang T-H, Chang C-S, Fu W-M, Yang R-S. Water solution of onion crude powder inhibits RANKL-induced osteoclastogenesis through ERK, p38 and NF-κB pathways. Osteoporos. Int. 2009;20:93-103. [PubMed ID: 18506384].
-
150.
Tucker KL, Hannan MT, Chen H, Cupples LA, Wilson PW, Kiel DP. Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am. J. Clin. Nutr. 1999;69:727-36. [PubMed ID: 10197575].
-
151.
Wattel A, Kamel S, Prouillet C, Petit JP, Lorget F, Offord E, Brazier M. Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NFκB and AP-1. J. Cell Biochem. 2004;92:285-95. [PubMed ID: 15108355].
-
152.
Oliveira T, Figueiredo CA, Brito C, Stavroullakis A, Ferreira AC, Nogueira-Filho G, Prakki A. Allium cepa L. and quercetin inhibit RANKL/porphyromonas gingivalis LPS-induced osteoclastogenesis by downregulating NF-κB signaling pathway. Evid. Based. Complement. Alternat. Med. 2015;2015:704781.
-
153.
Kanno S, Hirano S, Kayama F. Effects of the phytoestrogen coumestrol on RANK-ligand-induced differentiation of osteoclasts. Toxicology. 2004;203:211-20. [PubMed ID: 15363596].
-
154.
Park S, Kim MY, Lee DH, Lee SH, Baik EJ, Moon CH, Park SW, Ko EY, Oh SR, Jung YS. Methanolic extract of onion (Allium cepa) attenuates ischemia/hypoxia-induced apoptosis in cardiomyocytes via antioxidant effect. Eur. J. Nutr. 2009;48:235-42. [PubMed ID: 19234663].
-
155.
Kharadi GB, Patel KJ, Purohit BM, Baxi SN, Tripathi C. Evaluation of cardioprotective effect of aqueous extract of Allium cepa Linn bulb on isoprenaline-induced myocardial injury in Wistar albino rats. Res. Pharm. Sci. 2016;11:419-27. [PubMed ID: 27920825].
-
156.
Vazquez-Prieto MA, Rodriguez Lanzi C, Lembo C, Galmarini CR, Miatello RM. Garlic and onion attenuate vascular inflammation and oxidative stress in fructose-fed rats. J. Nutr. Metab. 2011;2011:475216. [PubMed ID: 21876795].
-
157.
Nausheen QN, Ali SA, Subur K. Cardioprotective and antioxidant activity of onion (Allium cepa) leaves extract in doxorubicin induced cardiotoxicity in rats. Ann. Exp. Biol. 2014;2:37-42.
-
158.
Sakai Y, Murakami T, Yamamoto Y. Antihypertensive effects of onion on NO synthase inhibitor-induced hypertensive rats and spontaneously hypertensive rats. Biosci. Biotechnol. Biochem. 2003;67:1305-11. [PubMed ID: 12843658].
-
159.
Fenwick GR, Hanley AB, Whitaker JR. The genus Allium-part 1. Crit. Rev. Food Sci. Nutr. 1985;22:199-271. [PubMed ID: 3902370].
-
160.
Chen J-H, Tsai S-J, Chen H-i. Welsh onion (Allium fistulosum L ) extracts alter vascular responses in rat aortae. J. Cardiovasc. Pharmacol. 1999;33:515-20. [PubMed ID: 10218719].
-
161.
Yeghaneh A. Hypolipidemic effects of aqueous extract of onion (Allium cepa Linn) on serum levels of cholesterol, triglycerides, LDL and HDL compared with Zn sulfate supplementation in the rats. J. Exp. Biol. 2012;2:1745-9.
-
162.
Hertog MG, Feskens EJ, Kromhout D, Hollman P, Katan M. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. The Lancet. 1993;342:1007-11.
-
163.
Erdman Jr JW, Balentine D, Arab L, Beecher G, Dwyer JT, Folts J, Harnly J, Hollman P, Keen CL, Mazza G, Messina M. Flavonoids and heart health: proceedings of the ILSI North America flavonoids workshop, May 31–June 1, 2005, Washington, DC. J. Nutr. 2007;137:718S-37S. [PubMed ID: 17311968].
-
164.
Arai Y, Watanabe S, Kimira M, Shimoi K, Mochizuki R, Kinae N. Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J. Nutr. 2000;130:2243-50. [PubMed ID: 10958819].
-
165.
Duarte J, Pérez-Palencia R, Vargas F, Ocete MA, Pérez-Vizcaino F, Zarzuelo A, Tamargo J. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br. J. Pharmacol. 2001;133:117-24. [PubMed ID: 11325801].
-
166.
Yamamoto Y, Oue E. Antihypertensive effect of quercetin in rats fed with a high-fat high-sucrose diet. Biosci. Biotechnol. Biochem. 2006;70:933-9. [PubMed ID: 16636461].
-
167.
OReilly JD, Mallet AI, McAnlis GT, Young IS, Halliwell B, Sanders TA, Wiseman H. Consumption of flavonoids in onions and black tea: lack of effect on F2-isoprostanes and autoantibodies to oxidized LDL in healthy humans. Am. J. Clin. Nutr. 2001;73:1040-4. [PubMed ID: 11382657].
-
168.
Steiner M, Khan AH, Holbert D, Lin R. A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids. Am. J. Clin. Nutr. 1996;64:866-70. [PubMed ID: 8942410].
-
169.
Augusti K, Chackery J, Jacob J, Kuriakose S, George S, Nair SS. Beneficial effects of a polar fraction of garlic (Allium sativum Linn) oil in rats fed with two different high fat diets. Indian. J. Exp. Biol. 2005;43:76-83. [PubMed ID: 15691069].
-
170.
Augusti K, Benaim M, Dewar H, Virden R. Partial identification of the fibrinolytic activators in onion. Atherosclerosis. 1975;21:409-16. [PubMed ID: 1148034].
-
171.
Kumari K, Augusti K. Antidiabetic and antioxidant effects of S-methyl cysteine sulfoxide isolated from onions (Allium cepa Linn) as compared to standard drugs in alloxan diabetic rats 2 Indian. J. Exp. Biol. 2002;40:1005-9.
-
172.
Kumari K, Mathew BC, Augusti K. Antidiabetic and hypolipidemic effects of S-methyl cysteine sulfoxide isolated from Allium cepa Linn. Indian. J. Biochem. Biophys. 1995;32:49-54. [PubMed ID: 7665195].
-
173.
Kumari K, Augusti K. Lipid lowering effect of S-methyl cysteine sulfoxide from Allium cepa Linn in high cholesterol diet fed rats. J. Ethnopharmacol. 2007;109:367-71. [PubMed ID: 16987625].
-
174.
Platel K, Srinivasan K. Studies on the influence of dietary spices on food transit time in experimental rats. Nutr. Res. 2001;21:130914.
-
175.
Benkeblia N, Shiomi N. Hydrolysis Kinetic Parameters of DP 6, 7, 8, and 9-12 Fructooligosaccharides (FOS) of Onion Bulb Tissues Effect of Temperature and Storage Time. J. Agric. Food Chem. 2006;54:2587-92. [PubMed ID: 16569048].
-
176.
Di Carlo G, Mascolo N, Izzo AA, Capasso F. Flavonoids: old and new aspects of a class of natural therapeutic drugs. Life. Sci. 1999;65:337-53. [PubMed ID: 10421421].
-
177.
Martin MJ, La-Casa C, Alarcon-de-La-Lastra C, Cabeza J, Villegas I, Motilva V. Anti-oxidant mechanisms involved in gastroprotective effects of quercetin. Z. Naturforsch. C. 1998;53:82-8. [PubMed ID: 9528125].
-
178.
de la Lastra A, Martin MJ, Motilva V. Antiulcer and gastroprotective effects of quercetin: a gross and histologic study. Pharmacology. 1994;48:56-62. [PubMed ID: 8309988].
-
179.
ur Rahman S, Khan S, Chand N, Sadique U, Khan RU. In-vivo effects of Allium cepa L on the selected gut microflora and intestinal histomorphology in broiler. Acta. Histochem. 2017;119:446-50. [PubMed ID: 28495367].
-
180.
Mehlhorn H, Al-Quraishy S, Al-Rasheid KA, Jatzlau A, Abdel-Ghaffar F. Addition of a combination of onion (Allium cepa) and coconut (Cocos nucifera) to food of sheep stops gastrointestinal helminthic infections. Parasitol. Res. 2011;108:1041-6. [PubMed ID: 21120531].
-
181.
Khajah MA, Orabi KY, Hawai S, Sary HG, EL-Hashim AZ. Onion bulb extract reduces colitis severity in mice via modulation of colonic inflammatory pathways and the apoptotic machinery. J. Ethnopharmacol. 2019;241:112008. [PubMed ID: 31158441].
-
182.
Singh T, Goel RK. Neuroprotective effect of Allium cepa in aluminium chloride induced neurotoxicity. Neurotoxicology. 2015;49:1-7. [PubMed ID: 25940660].
-
183.
Patil BS, Pike LM, Yoo KS. Variation in the quercetin content in different colored onions (Allium cepa L ). J. Am. Soc. Hortic. Sci. 1995;120:909-13.
-
184.
Cook N, Samman S. Flavonoids-chemistry, metabolism, cardioprotective effects, and dietary sources. J. Nutr. Biochem. 1996;7:66-76.
-
185.
Xiao H, Parkin KL. Antioxidant functions of selected allium thiosulfinates and S-alk (en) yl-L-cysteine sulfoxides. J. Agric. Food Chem. 2002;50:2488-93. [PubMed ID: 11958610].
-
186.
Rose P, Whiteman M, Moore PK, Zhu YZ. Bioactive S-alk (en) yl cysteine sulfoxide metabolites in the genus Allium: the chemistry of potential therapeutic agents. Nat. Prod. Rep. 2005;22:351-68. [PubMed ID: 16010345].
-
187.
Tamtaji OR, Hosseinzadeh H, Talaei SA, Behnam M, Firoozeh SM, Taghizadeh M, Alipoor R. Protective Effects of Red Onion (Allium cepa) Ethanolic Extract on Learning and Memory Impairments in Animal Models of Diabetes. GMJ. 2017;6:249-57.
-
188.
Samad N, Saleem A. Administration of Allium cepa bulb attenuates stress-produced anxiety and depression and improves memory in male mice. Metab. Brain. Dis. 2018;33:271-81. [PubMed ID: 29178012].
-
189.
Dorsch W, Adam O, Weber J. Antiallergic and antiasthmatic effects of onion extracts. Folia. Allergol. Immunol. Clin. 1983;30:17.
-
190.
Dorsch W, Weber J. Prevention of allergen-induced bronchial obstruction in sensitized guinea pigs by crude alcoholic onion extract. Agents. Actions. Suppl. 1984;14:626-9.
-
191.
Oliveira TT, Campos KM, Cerqueira-Lima AT, Carneiro TC, da Silva Velozo E, Melo IC, Figueiredo EA, de Jesus Oliveira E, de Vasconcelos DF, Pontes-de-Carvalho LC, Alcântara-Neves NM. Potential therapeutic effect of Allium cepa L and quercetin in a murine model of Blomia tropicalis induced asthma. Daru. 2015;23:18.
-
192.
Ghorani V, Marefati N, Shakeri F, Rezaee R, Boskabady M, Boskabady MH. The Effects of Allium Cepa Extract on Tracheal Responsiveness, Lung Inflammatory Cells and Phospholipase A2 Level in Asthmatic Rats. Iran. J. Allergy. Asthma. Immunol. 2018;17:221-31. [PubMed ID: 29908539].
-
193.
Marefati N, Eftekhar N, Kaveh M, Boskabadi J, Beheshti F, Boskabady MH. The Effect of Allium cepa Extract on Lung Oxidant, Antioxidant, and Immunological Biomarkers in Ovalbumin-Sensitized Rats. Med. Princ. Pract. 2018;27:122-8. [PubMed ID: 29471299].
-
194.
Helen A, Krishnakumar K, Vijayammal P, Augusti K. Antioxidant effect of onion oil (Allium cepa Linn) on the damages induced by nicotine in rats as compared to alpha-tocopherol. Toxicol. Lett. 2000;116:61-8. [PubMed ID: 10906423].
-
195.
Ogadinma I, Chuemere AN, Vitalis V. Evaluation of aromatherapeutic potential of Allium cepa in carbon monoxide-induced respiratory tissue toxicity in wistar rats. AJPSci. 2018:1-7.
-
196.
Zaki SM. Evaluation of antioxidant and anti-lipid peroxidation potentials of Nigella sativa and onion extract on nicotine-induced lung damage. Folia. Morphol. 2019;78:554-63.
-
197.
Seo MY, Kim KR, Lee JJ, Ryu G, Lee SH, Hong SD, Dhong HJ, Baek CH, Chung SK, Kim HY. Therapeutic effect of topical administration of red onion extract in a murine model of allergic rhinitis. Sci. Rep. 2019;9:2883.
-
198.
Marzocchella L, Fantini M, Benvenuto M, Masuelli L, Tresoldi I, Modesti A, Bei R. Dietary flavonoids: molecular mechanisms of action as anti-inflammatory agents. Recent. Pat. Inflamm. Allergy. Drug. Discov. 2011;5:200-20. [PubMed ID: 21827399].
-
199.
Gulsen A, Makris DP, Kefalas P. Biomimetic oxidation of quercetin: isolation of a naturally occurring quercetin heterodimer and evaluation of its in-vitro antioxidant properties. Food Res. Int. 2007;40:7-14.
-
200.
Kawai M, Hirano T, Higa S, Arimitsu J, Maruta M, Kuwahara Y, Ohkawara T, Hagihara K, Yamadori T, Shima Y, Ogata A. Flavonoids and related compounds as anti-allergic substances. Allergol. Int. 2007;56:113-23. [PubMed ID: 17384531].
-
201.
Tanaka T, Takahashi R. Flavonoids and asthma. Nutrients. 2013;5:2128-43. [PubMed ID: 23752494].
-
202.
Nair MP, Kandaswami C, Mahajan S, Chadha KC, Chawda R, Nair H, Kumar N, Nair RE, Schwartz SA. The flavonoid, quercetin, differentially regulates Th-1 (IFNγ) and Th-2 (IL4) cytokine gene expression by normal peripheral blood mononuclear cells. Biochim. Biophys. Acta. Mol. Cell. Res. 2002;1593:29-36.
-
203.
Lombard KA. Investigation of the flavonol quercetin in onion (Allium cepa L ) by high-performance liquid chromatography (HPLC) and spectrophotometric methodology. Texas Tech. University; 2000.
-
204.
Thornhill SM, Kelly AM. Natural treatment of perennial allergic rhinitis. Altern. Med. Rev. 2000;5:448-54. [PubMed ID: 11056414].
-
205.
Finn D, Walsh J. Twenty-first century mast cell stabilizers. Br. J. Pharmacol. 2013;170:23-37. [PubMed ID: 23441583].
-
206.
Singh A, Holvoet S, Mercenier A. Dietary polyphenols in the prevention and treatment of allergic diseases. Allergy. 2011;41:1346-59.
-
207.
Joskova M, Franova S, Sadlonova V. Acute bronchodilator effect of quercetin in experimental allergic asthma. Bratisl. Lek. Listy. 2011;112:9-12. [PubMed ID: 21452772].
-
208.
M Calderon-Montano J, Burgos-Morón E, Pérez-Guerrero C, López-Lázaro M. A review on the dietary flavonoid kaempferol. Mini Rev. Med. Chem. 2011;11:298-344. [PubMed ID: 21428901].
-
209.
Rogerio AP, Kanashiro A, Fontanari C, da Silva EV, Lucisano-Valim YM, Soares EG, Faccioli LH. Anti-inflammatory activity of quercetin and isoquercitrin in experimental murine allergic asthma. Inflamm. Res. 2007;56:402-8. [PubMed ID: 18026696].
-
210.
Park HJ, Lee CM, Jung ID, Lee JS, Jeong YI, Chang JH, Chun SH, Kim MJ, Choi IW, Ahn SC, Shin YK. Quercetin regulates Th1/Th2 balance in a murine model of asthma. Int. Immunopharmacol. 2009;9:261-7. [PubMed ID: 19061976].
-
211.
Kumazawa Y, Takimoto H, Matsumoto T, Kawaguchi K. Potential use of dietary natural products, especially polyphenols, for improving type-1 allergic symptoms. Curr. Pharm. Des. 2014;20:857-63. [PubMed ID: 23701564].
-
212.
Dorsch W. Allium cepa L (Onion): Part 2 chemistry, analysis and pharmacology. Phytomedicine. 1997;3:391-7. [PubMed ID: 23195199].
-
213.
Memarzia A, Amin F, Saadat S, Jalali M, Ghasemi Z, Boskabady MH. The contribution of beta-2 adrenergic, muscarinic and histamine (H1) receptors, calcium and potassium channels and cyclooxygenase pathway in the relaxant effect of Allium cepa L on the tracheal smooth muscle. J. Ethnopharmacol. 2019;241:112012. [PubMed ID: 31170518].
-
214.
Capasso R, Aviello G, Romano B, Atorino G, Pagano E, Borrelli F. Inhibitory effect of quercetin on rat trachea contractility in vitro. J. Pharm. Pharmacol. 2009;61:115-9. [PubMed ID: 19126305].
-
215.
Fernandez J, Reyes R, Ponce H, Oropeza M, Vancalsteren MR, Jankowski C, Campos MG. Isoquercitrin from Argemone platyceras inhibits carbachol and leukotriene D4-induced contraction in guinea-pig airways. Eur. J. Pharmacol. 2005;522:108-5. [PubMed ID: 16202993].
-
216.
Valdivieso R, Subiza J, Varela-Losada S, Subiza JL, Narganes MJ, MartinezCocera C, Cabrera M. Bronchial asthma, rhinoconjunctivitis, and contact dermatitis caused by onion. J. Allergy. Clin. Immunol. 1994;94:928-30. [PubMed ID: 7963160].
-
217.
Enrique E, Malek T, De Mateo JA, Castelló J, Lombardero M, Barber D, Salcedo G. Involvement of lipid transfer protein in onion allergy. Ann. Allergy Asthma Immunol. 2007;98:202. [PubMed ID: 17304894].
-
218.
Lakhanpal P, Rai DK. Quercetin: a versatile flavonoid. IJMU. 2007;2:22-37.
-
219.
Elberry AA, Mufti S, Al-Maghrabi J, Abdel Sattar E, Ghareib SA, Mosli HA, Gabr SA. Immunomodulatory effect of red onion (Allium cepa Linn) scale extract on experimentally induced atypical prostatic hyperplasia in Wistar rats. Mediators. Inflamm. 2014;2014:640746. [PubMed ID: 24829522].
-
220.
Shoskes DA, Zeitlin SI, Shahed A, Rajfer J. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology. 1999;54:960-3. [PubMed ID: 10604689].
-
221.
Ashteani A. Effect of Allium Cepa seeds ethanolic extract, on Serum total antioxidant in experimental induced poly cystic ovarian (PCO) rats. Life. Sci. J. 2013:10.
-
222.
Ghasemzadeh A, Farzadi L, Khaki A, Ahmadi SK. Effect of Allium cepa seeds ethanolic extract on experimental polycystic ovary syndrome (PCOS) apoptosis induced by estradiol-valerate. Life Sci. J. 2013;10:170-5.
-
223.
Bianchini F, Vainio H. Allium vegetables and organosulfur compounds: do they help prevent cancer? Environ. Health Perspect. 2001;109:893-902.